Marc C. Hochberg

Marc C. Hochberg's AcademicInfluence.com Rankings

Marc C. Hochberg

Medical

#691

World Rank

#917

Historical Rank

Rheumatology

World Rank

Historical Rank

medical Degrees

Download Badge

Medical

Why Is Marc C. Hochberg Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Marc C. Hochberg's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Development of criteria for the classification and reporting of osteoarthritis. Classification of osteoarthritis of the knee. Diagnostic and Therapeutic Criteria Committee of the American Rheumatism Association. (1986) (6249)
Estimates of the prevalence of arthritis and other rheumatic conditions in the United States. Part II. (2008) (5019)
Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis. VIGOR Study Group. (2000) (3113)
Estimates of the prevalence of arthritis and selected musculoskeletal disorders in the United States. (1998) (2756)
OARSI recommendations for the management of hip and knee osteoarthritis, Part II: OARSI evidence-based, expert consensus guidelines. (2008) (2699)
American College of Rheumatology 2012 recommendations for the use of nonpharmacologic and pharmacologic therapies in osteoarthritis of the hand, hip, and knee (2012) (2699)
Recommendations for the medical management of osteoarthritis of the hip and knee: 2000 update. American College of Rheumatology Subcommittee on Osteoarthritis Guidelines. (2000) (1843)
OARSI recommendations for the management of hip and knee osteoarthritis: part III: Changes in evidence following systematic cumulative update of research published through January 2009. (2010) (1671)
American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis. (2008) (1476)
Vascular and upper gastrointestinal effects of non-steroidal anti-inflammatory drugs: meta-analyses of individual participant data from randomised trials (2013) (1418)
Atlas of individual radiographic features in osteoarthritis. (1995) (1044)
Fracture risk reduction with alendronate in women with osteoporosis: the Fracture Intervention Trial. FIT Research Group. (2000) (977)
Guidelines for the medical management of osteoarthritis (1995) (870)
Evaluation of clinically relevant changes in patient reported outcomes in knee and hip osteoarthritis: the minimal clinically important improvement (2004) (858)
Comparison of 2 frailty indexes for prediction of falls, disability, fractures, and death in older women. (2008) (840)
OARSI recommendations for the management of hip and knee osteoarthritis, part I: critical appraisal of existing treatment guidelines and systematic review of current research evidence. (2007) (834)
Guidelines for the medical management of osteoarthritis. Part II. Osteoarthritis of the knee. American College of Rheumatology. (1995) (833)
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update. American College of Rheumatology Ad Hoc Committee on Glucocorticoid-Induced Osteoporosis. (1996) (823)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2020) (753)
OMERACT-OARSI initiative: Osteoarthritis Research Society International set of responder criteria for osteoarthritis clinical trials revisited. (2004) (716)
Joint Injury in Young Adults and Risk for Subsequent Knee and Hip Osteoarthritis (2000) (713)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), reduction in ulcer complications: randomised controlled trial (2004) (680)
Glucosamine therapy for treating osteoarthritis. (2005) (658)
Risk factors for coronary artery disease in patients with systemic lupus erythematosus. (1992) (641)
Effectiveness of Acupuncture as Adjunctive Therapy in Osteoarthritis of the Knee (2004) (625)
Frailty and risk of falls, fracture, and mortality in older women: the study of osteoporotic fractures. (2007) (612)
Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 Update: American College of Rheumatology Ad Hoc Committee on glucocorticoid-induced osteoporosis (2001) (609)
Hip fracture in women without osteoporosis. (2005) (570)
Estimates of the prevalence of selected arthritic and musculoskeletal diseases in the United States. (1989) (543)
Prevalence of knee symptoms and radiographic and symptomatic knee osteoarthritis in African Americans and Caucasians: the Johnston County Osteoarthritis Project. (2007) (536)
Osteoarthritis: New Insights. Part 2: Treatment Approaches (2000) (519)
Design and conduct of clinical trials in patients with osteoarthritis : Recommendations from a task force of the Osteoarthritic Research Society (1996) (508)
Osteoarthritis I: epidemiology. (1984) (499)
Meniscal tear and extrusion are strongly associated with progression of symptomatic knee osteoarthritis as assessed by quantitative magnetic resonance imaging (2004) (484)
Comparison of lumiracoxib with naproxen and ibuprofen in the Therapeutic Arthritis Research and Gastrointestinal Event Trial (TARGET), cardiovascular outcomes: randomised controlled trial (2004) (483)
Acetaminophen for osteoarthritis. (2006) (482)
Changes in bone density and turnover explain the reductions in incidence of nonvertebral fractures that occur during treatment with antiresorptive agents. (2002) (479)
2019 American College of Rheumatology/Arthritis Foundation Guideline for the Management of Osteoarthritis of the Hand, Hip, and Knee (2020) (478)
Prevalent Vertebral Deformities Predict Mortality and Hospitalization in Older Women with Low Bone Mass (2000) (447)
Evaluation of clinically relevant states in patient reported outcomes in knee and hip osteoarthritis: the patient acceptable symptom state (2004) (441)
An algorithm recommendation for the management of knee osteoarthritis in Europe and internationally: a report from a task force of the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). (2014) (437)
Factors associated with functional impairment in symptomatic knee osteoarthritis. (2000) (412)
Change in Bone Turnover and Hip, Non‐Spine, and Vertebral Fracture in Alendronate‐Treated Women: The Fracture Intervention Trial (2004) (387)
A meta-analysis of the incidence of malignancy in adult patients with rheumatoid arthritis (2008) (385)
Systemic Lupus Erythematosus: A Review of Clinico‐Laboratory Features and Immunogenetic Markers in 150 Patients with Emphasis on Demographic Subsets (1985) (377)
The burden of musculoskeletal conditions at the start of the new millennium (2003) (362)
Prevalence of Hip Symptoms and Radiographic and Symptomatic Hip Osteoarthritis in African Americans and Caucasians: The Johnston County Osteoarthritis Project (2009) (361)
Osteoarthritis (1997) (360)
Radiographic osteoarthritis of the hip and bone mineral density. The Study of Osteoporotic Fractures Research Group. (1995) (360)
Treatment With Once‐Weekly Alendronate 70 mg Compared With Once‐Weekly Risedronate 35 mg in Women With Postmenopausal Osteoporosis: A Randomized Double‐Blind Study (2004) (352)
Tumour necrosis factor antagonist use and associated risk reduction of cardiovascular events among patients with rheumatoid arthritis (2010) (337)
OARSI-FDA initiative: defining the disease state of osteoarthritis. (2011) (336)
Psychological interventions for rheumatoid arthritis: a meta-analysis of randomized controlled trials. (2002) (324)
Factors associated with hip osteoarthritis: data from the First National Health and Nutrition Examination Survey (NHANES-I). (1993) (318)
Definition, incidence, and clinical description of flare in systemic lupus erythematosus. A prospective cohort study. (1991) (316)
Determinants of pain severity in knee osteoarthritis: effect of demographic and psychosocial variables using 3 pain measures. (1999) (302)
Effect of Mindfulness-Based Stress Reduction in rheumatoid arthritis patients. (2007) (300)
Minimum clinically important improvement and patient acceptable symptom state in pain and function in rheumatoid arthritis, ankylosing spondylitis, chronic back pain, hand osteoarthritis, and hip and knee osteoarthritis: Results from a prospective multinational study (2012) (292)
Larger increases in bone mineral density during alendronate therapy are associated with a lower risk of new vertebral fractures in women with postmenopausal osteoporosis. Fracture Intervention Trial Research Group. (1999) (289)
Acupuncture for osteoarthritis of the knee: a systematic review. (2001) (286)
Reliability of new indices of radiographic osteoarthritis of the hand and hip and lumbar disc degeneration. (1993) (284)
Explaining the cardiovascular risk associated with rheumatoid arthritis: traditional risk factors versus markers of rheumatoid arthritis severity (2010) (283)
Recommendations for the Medical Management of Osteoarthrits of the Hip and Knee (2002) (282)
Guidelines for the medical management of osteoarthritis. Part I. Osteoarthritis of the hip. American College of Rheumatology. (1995) (276)
Clinical Use of Biochemical Markers of Bone Remodeling: Current Status and Future Directions (2000) (276)
Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis (2015) (274)
The risk of hospitalized infection in patients with rheumatoid arthritis. (2008) (274)
Quantitative magnetic resonance imaging evaluation of knee osteoarthritis progression over two years and correlation with clinical symptoms and radiologic changes. (2004) (274)
Health economics in the field of osteoarthritis: an expert's consensus paper from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). (2013) (269)
The association of body weight, body fatness and body fat distribution with osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. (1995) (269)
Randomized Trial of Effect of Alendronate Continuation Versus Discontinuation in Women With Low BMD: Results From the Fracture Intervention Trial Long‐Term Extension (2004) (269)
Body mass index in young men and the risk of subsequent knee and hip osteoarthritis. (1999) (268)
Alendronate Treatment in Women With Normal to Severely Impaired Renal Function: An Analysis of the Fracture Intervention Trial (2007) (268)
The risk of herpes zoster in patients with rheumatoid arthritis in the United States and the United Kingdom. (2007) (263)
Guidelines for the medical management of osteoarthritis. II: Osteoarthritis of the knee (1995) (263)
Back Pain Exacerbations and Lost Productive Time Costs in United States Workers (2006) (258)
Dry eye and dry mouth in the elderly: a population-based assessment. (1999) (255)
Coronary Artery Disease Risk Factors in the Johns Hopkins Lupus Cohort: Prevalence, Recognition by Patients, and Preventive Practices (1992) (252)
A randomized trial of acupuncture as an adjunctive therapy in osteoarthritis of the knee. (1999) (251)
The efficacy of mindfulness meditation plus Qigong movement therapy in the treatment of fibromyalgia: a randomized controlled trial. (2003) (251)
Outcome variables for osteoarthritis clinical trials: The OMERACT-OARSI set of responder criteria. (2003) (250)
Musculoskeletal Pain and Risk for Falls in Older Disabled Women Living in the Community (2002) (247)
Incidence and risk factors for gout in white men. (1991) (246)
Association of methotrexate and tumour necrosis factor antagonists with risk of infectious outcomes including opportunistic infections in the CORRONA registry (2009) (246)
Bone mineral density and the risk of incident nonspinal fractures in black and white women. (2005) (242)
Exercise Rehabilitation Improves Functional Outcomes and Peripheral Circulation in Patients with Intermittent Claudication: A Randomized Controlled Trial (2001) (241)
Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial. (2015) (235)
Association of estrogen replacement therapy with the risk of osteoarthritis of the hip in elderly white women. Study of Osteoporotic Fractures Research Group. (1996) (231)
Long-term risk of incident vertebral fractures. (2007) (225)
A consensus statement on the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO) algorithm for the management of knee osteoarthritis-From evidence-based medicine to the real-life setting. (2016) (219)
Prevalence of rheumatoid arthritis in persons 60 years of age and older in the United States: effect of different methods of case classification. (2003) (217)
Risk Factors for a First‐Incident Radiographic Vertebral Fracture in Women ≥65 Years of Age: The Study of Osteoporotic Fractures (2004) (217)
Upper gastrointestinal tract safety profile of alendronate: the fracture intervention trial. (2000) (217)
Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events (2015) (216)
Combined chondroitin sulfate and glucosamine for painful knee osteoarthritis: a multicentre, randomised, double-blind, non-inferiority trial versus celecoxib (2015) (216)
The benefit/risk profile of TNF-blocking agents: findings of a consensus panel. (2005) (214)
Relationship between C4 null genes, HLA-D region antigens, and genetic susceptibility to systemic lupus erythematosus in Caucasian and black Americans. (1986) (212)
Comparison of the efficacy of the tumour necrosis factor α blocking agents adalimumab, etanercept, and infliximab when added to methotrexate in patients with active rheumatoid arthritis (2003) (209)
Validity and reliability of lupus activity measures in the routine clinic setting. (1992) (209)
Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: A longitudinal study (1999) (206)
Recommendations for the Use of Nonpharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand , Hip , and Knee (2012) (203)
Objective physical activity measurement in the osteoarthritis initiative: Are guidelines being met? (2011) (201)
Osteoarthritis and risk of falls, rates of bone loss, and osteoporotic fractures. Study of Osteoporotic Fractures Research Group. (1999) (197)
New radiographic grading scales for osteoarthritis of the hand. Reliability for determining prevalence and progression. (1989) (197)
Design and conduct of clinical trials in patients with osteoarthritis: recommendations from a task force of the Osteoarthritis Research Society. Results from a workshop. (1996) (196)
Very low prevalence of hip osteoarthritis among Chinese elderly in Beijing, China, compared with whites in the United States: the Beijing osteoarthritis study. (2002) (193)
Widespread Musculoskeletal Pain and the Progression of Disability in Older Disabled Women (2001) (192)
Two Ro (SS-A) autoantibody responses in systemic lupus erythematosus. Correlation of HLA-DR/DQ specificities with quantitative expression of Ro (SS-A) autoantibody. (1988) (191)
Efficacy of continued alendronate for fractures in women with and without prevalent vertebral fracture: The FLEX Trial (2010) (181)
Effect of Intra-Articular Sprifermin vs Placebo on Femorotibial Joint Cartilage Thickness in Patients With Osteoarthritis: The FORWARD Randomized Clinical Trial. (2019) (179)
Association of mild acetabular dysplasia with an increased risk of incident hip osteoarthritis in elderly white women: the study of osteoporotic fractures. (2000) (178)
Pretreatment Levels of Bone Turnover and the Antifracture Efficacy of Alendronate: The Fracture Intervention Trial (2005) (173)
Mortality Associated with Caregiving, General Stress, and Caregiving‐Related Stress in Elderly Women: Results of Caregiver‐Study of Osteoporotic Fractures (2010) (172)
Association of radiographic features of osteoarthritis of the knee with knee pain: data from the Baltimore Longitudinal Study of Aging. (1995) (171)
The role of pain and functional impairment in the decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1909 patients. Report of the OARSI-OMERACT Task Force on total joint replacement. (2011) (168)
The associations of bone mineral density and bone turnover markers with osteoarthritis of the hand and knee in pre- and perimenopausal women. (1999) (168)
Juvenile dermatomyositis at diagnosis: clinical characteristics of 79 children. (1998) (167)
Factors that modify the association between knee pain and mobility limitation in older women: the Women's Health and Aging Study (2000) (167)
Systemic lupus erythematosus. (1990) (165)
Adult and juvenile rheumatoid arthritis: current epidemiologic concepts. (1981) (165)
Foot pain and disability in older women. (1998) (160)
Meta-analysis of the efficacy of alendronate for the prevention of hip fractures in postmenopausal women (2005) (155)
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status (1992) (153)
Reliability of a quantification imaging system using magnetic resonance images to measure cartilage thickness and volume in human normal and osteoarthritic knees. (2003) (153)
Performance of risk indices for identifying low bone density in postmenopausal women. (2002) (150)
Higher risk of multiple falls among elderly women who lose visual acuity. (2004) (148)
Circulating 25-hydroxyvitamin D levels and frailty status in older women. (2010) (147)
Aspirin and NSAID use in older women: Effect on bone mineral density and fracture risk (1996) (146)
The ACTTION-American Pain Society Pain Taxonomy (AAPT): an evidence-based and multidimensional approach to classifying chronic pain conditions. (2014) (146)
Bone mineral density and osteoarthritis: data from the Baltimore Longitudinal Study of Aging. (2004) (143)
C-reactive protein as a biomarker of emergent osteoarthritis. (2002) (137)
Prevalence of Pelvic Paget's Disease of Bone in the United States (2000) (137)
Serum immunoreactive erythropoietin in rheumatoid arthritis: impaired response to anemia. (1988) (136)
Knee pain and knee osteoarthritis severity in self-reported task specific disability: the Johnston County Osteoarthritis Project. (1997) (135)
Estradiol and its metabolites and their association with knee osteoarthritis. (2006) (134)
Morbidity of systemic lupus erythematosus: role of race and socioeconomic status. (1991) (134)
Familial aggregation of osteoarthritis: data from the Baltimore Longitudinal Study on Aging. (1998) (133)
Association of bone mineral density and sex hormone levels with osteoarthritis of the hand and knee in premenopausal women. (1996) (133)
Effects of gastroprotectant drugs for the prevention and treatment of peptic ulcer disease and its complications: a meta-analysis of randomised trials (2018) (132)
Ethnic and sex differences in serum levels of cartilage oligomeric matrix protein: the Johnston County Osteoarthritis Project. (2003) (131)
The application of genetic epidemiology to systemic lupus erythematosus. (1987) (131)
Fracture prediction after discontinuation of 4 to 5 years of alendronate therapy: the FLEX study. (2014) (131)
Evaluating the value of repeat bone mineral density measurement and prediction of fractures in older women: the study of osteoporotic fractures. (2007) (131)
Non-surgical management of knee osteoarthritis: comparison of ESCEO and OARSI 2019 guidelines (2020) (129)
Design and conduct of clinical trials in patients with osteoarthritis of the hand: recommendations from a task force of the Osteoarthritis Research Society International. (2006) (129)
When Is Osteonecrosis Not Osteonecrosis?: Adjudication of Reported Serious Adverse Joint Events in the Tanezumab Clinical Development Program (2016) (128)
Reliability of grading scales for individual radiographic features of osteoarthritis of the knee. The Baltimore longitudinal study of aging atlas of knee osteoarthritis. (1993) (127)
Radiographically defined osteoarthritis of the hand and knee in young and middle-aged African American and Caucasian women. (2000) (126)
Serious joint-related adverse events in randomized controlled trials of anti-nerve growth factor monoclonal antibodies. (2015) (125)
Low back pain and disability in older women: independent association with difficulty but not inability to perform daily activities. (1999) (125)
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition (2019) (125)
Mortality in osteoarthritis. (2008) (124)
Serum hyaluronan levels and radiographic knee and hip osteoarthritis in African Americans and Caucasians in the Johnston County Osteoarthritis Project. (2005) (123)
Acetaminophen for osteoarthritis. (2006) (122)
Malignancies in the rheumatoid arthritis abatacept clinical development programme: an epidemiological assessment (2008) (122)
Incidence of lung cancer in systemic sclerosis. (1985) (122)
Racial differences in the incidence of gout. The role of hypertension. (1995) (121)
OARSI-OMERACT definition of relevant radiological progression in hip/knee osteoarthritis. (2009) (119)
COX-2 selective inhibitors in the treatment of osteoarthritis. (2008) (117)
Progression of radiographic hip osteoarthritis over eight years in a community sample of elderly white women. (2004) (117)
The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytic epidemiological studies using meta-analysis. (1990) (112)
One Hundred Anti‐Ro (SS‐A) Antibody Positive Patients: A 10‐Year Follow‐Up (1995) (112)
Sjögren's syndrome. Influence of multiple HLA-D region alloantigens on clinical and serologic expression. (1984) (112)
A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the knee, with an emphasis on trial methodology. (1997) (112)
Primary Sjögren's syndrome in men. Clinical, serologic, and immunogenetic features. (1986) (112)
Where does it hurt? Pain localization in osteoarthritis of the knee. (1998) (112)
The relationship of anxiety and depression with self-reported knee pain in the community: data from the Baltimore Longitudinal Study of Aging. (1999) (111)
Epidemiology of chronic musculoskeletal disorders. (1988) (111)
Body mass index is positively associated with bone mineral density in US older adults (2014) (110)
Safety of Abatacept Administered Intravenously in Treatment of Rheumatoid Arthritis: Integrated Analyses of up to 8 Years of Treatment from the Abatacept Clinical Trial Program (2013) (110)
Self-reported functional status in osteoarthritis of the knee in a rural southern community: the role of sociodemographic factors, obesity, and knee pain. (1996) (109)
Pain exacerbation as a major source of lost productive time in US workers with arthritis. (2005) (109)
Association between serum 25(OH) vitamin D and the risk of cognitive decline in older women. (2012) (109)
Effects of Current and Discontinued Estrogen Replacement Therapy on Hip Structural Geometry: The Study of Osteoporotic Fractures * (2001) (107)
Binocular Visual‐Field Loss Increases the Risk of Future Falls in Older White Women (2007) (106)
OMERACT/OARSI initiative to define states of severity and indication for joint replacement in hip and knee osteoarthritis. (2007) (104)
Relation of physical activity time to incident disability in community dwelling adults with or at risk of knee arthritis: prospective cohort study (2014) (104)
Early detection of radiographic knee osteoarthritis using computer-aided analysis. (2009) (104)
Suggested guidelines for evaluation and treatment of glucocorticoid-induced osteoporosis for the Department of Veterans Affairs. (2003) (103)
Indirect comparison of tocilizumab and other biologic agents in patients with rheumatoid arthritis and inadequate response to disease-modifying antirheumatic drugs. (2010) (103)
Caregiving intensity and change in physical functioning over a 2-year period: results of the caregiver-study of osteoporotic fractures. (2009) (102)
Assessing physical activity in persons with knee osteoarthritis using accelerometers: Data from the osteoarthritis initiative (2010) (101)
Longitudinal Study of Changes in Hip Bone Mineral Density in Caucasian and African‐American Women (2005) (101)
Sustained improvement produced by nonpharmacologic intervention in fibromyalgia: results of a pilot study. (2000) (99)
Measurement of structural progression in osteoarthritis of the hip: the Barcelona consensus group. (2004) (99)
Epidemiology of rheumatoid arthritis: update. (1990) (99)
Comparison of weekly treatment of postmenopausal osteoporosis with alendronate versus risedronate over two years. (2006) (98)
The Genetics of Generalized Osteoarthritis (GOGO) study: study design and evaluation of osteoarthritis phenotypes. (2007) (97)
Pins and plaster aren't enough: a call for the evaluation and treatment of patients with osteoporotic fractures. (2003) (97)
Leisure-time exercise and overall physical activity in older women caregivers and non-caregivers from the Caregiver-SOF Study. (2006) (97)
The relationship between psychosocial variables and pain reporting in osteoarthritis of the knee. (1998) (96)
Commentary on recent therapeutic guidelines for osteoarthritis. (2015) (95)
Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain (2018) (95)
Serum vitamin D levels and incident changes of radiographic hip osteoarthritis: a longitudinal study. Study of Osteoporotic Fractures Research Group. (1999) (95)
Infliximab for the treatment of rheumatoid arthritis. (2002) (95)
Comparative cancer risk associated with methotrexate, other non-biologic and biologic disease-modifying anti-rheumatic drugs. (2014) (94)
Delivery and outcomes of a yearlong home exercise program after hip fracture: a randomized controlled trial. (2011) (93)
Structure-modifying effects of chondroitin sulfate in knee osteoarthritis: an updated meta-analysis of randomized placebo-controlled trials of 2-year duration. (2010) (93)
Effect of Alendronate on the Age‐Specific Incidence of Symptomatic Osteoporotic Fractures (2005) (93)
Effects of antiinflammatory and immunosuppressive drugs on pregnancy and fertility. (1988) (93)
A novel Wnt pathway inhibitor, SM04690, for the treatment of moderate to severe osteoarthritis of the knee: results of a 24-week, randomized, controlled, phase 1 study. (2017) (93)
Association of hand and knee osteoarthritis: evidence for a polyarticular disease subset. (1996) (93)
What is the predictive value of MRI for the occurrence of knee replacement surgery in knee osteoarthritis? (2013) (92)
First-line analysis of the effects of treatment on progression of structural changes in knee osteoarthritis over 24 months: data from the osteoarthritis initiative progression cohort. (2015) (92)
Obesity and other modifiable factors for physical inactivity measured by accelerometer in adults with knee osteoarthritis (2013) (90)
FRAX and Risk of Vertebral Fractures: The Fracture Intervention Trial (2009) (90)
Prevalent Vertebral Fractures in Black Women and White Women (2008) (89)
Quality of osteoarthritis management and the need for reform in the US (2011) (89)
Articular hypermobility is a protective factor for hand osteoarthritis. (2004) (89)
Duloxetine added to oral nonsteroidal anti-inflammatory drugs for treatment of knee pain due to osteoarthritis: results of a randomized, double-blind, placebo-controlled trial (2011) (86)
Changes in the incidence and prevalence of rheumatoid arthritis in England and Wales, 1970-1982. (1990) (86)
Preferences in the management of osteoarthritis of the hip and knee: results of a survey of community-based rheumatologists in the United States. (1996) (85)
Lack of association between augmentation mammoplasty and systemic sclerosis (scleroderma). (1996) (85)
Gout and risk for subsequent coronary heart disease. The Meharry-Hopkins Study. (1997) (85)
Glaucoma risk and the consumption of fruits and vegetables among older women in the study of osteoporotic fractures. (2008) (84)
Carbon monoxide diffusing capacity as predictor of outcome in systemic sclerosis. (1984) (84)
Vitamin D deficiency is associated with progression of knee osteoarthritis. (2014) (83)
An association between an aggrecan polymorphic allele and bilateral hand osteoarthritis in elderly white men: data from the Baltimore Longitudinal Study of Aging (BLSA). (1998) (83)
The Epidemiology of Low- and High-Energy Distal Radius Fracture in Middle-Aged and Elderly Men and Women in Southern Norway (2012) (82)
Type 2 diabetes mellitus and osteoarthritis. (2019) (82)
Inflammatory Markers and Risk of Hip Fracture in Older White Women: The Study of Osteoporotic Fractures (2014) (81)
Prevalence of self-reported physician-diagnosed systemic lupus erythematosus in the USA (1995) (81)
Differences in radiographic features of knee osteoarthritis in African-Americans and Caucasians: the Johnston county osteoarthritis project. (2009) (81)
Significance of Preradiographic Magnetic Resonance Imaging Lesions in Persons at Increased Risk of Knee Osteoarthritis (2014) (81)
Frequency of varus and valgus thrust and factors associated with thrust presence in persons with or at higher risk of developing knee osteoarthritis. (2010) (81)
The risk of cardiovascular thrombotic events with selective cyclooxygenase-2 inhibitors. (2002) (80)
Why does osteoarthritis of the knee hurt--sometimes? (1997) (80)
Mortality after elective total hip arthroplasty in elderly Americans. Age, gender, and indication for surgery predict survival. (1993) (80)
Physical disability and psychosocial dysfunction in systemic lupus erythematosus. (1988) (79)
Racial Differences in Rate of Decline in Bone Mass in Older Men: The Baltimore Men's Osteoporosis Study (2005) (78)
The association of consumption of fruits/vegetables with decreased risk of glaucoma among older African-American women in the study of osteoporotic fractures. (2012) (78)
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006 (2008) (78)
Health-related quality of life after total hip replacement. (1996) (77)
OARSI/OMERACT Initiative to Define States of Severity and Indication for Joint Replacement in Hip and Knee Osteoarthritis. An OMERACT 10 Special Interest Group (2011) (77)
Development of Multinational Definitions of Minimal Clinically Important Improvement and Patient Acceptable Symptomatic State in Osteoarthritis (2015) (76)
The longitudinal course of hand osteoarthritis in a male population. (1990) (76)
Prevalence of symptoms of dry mouth and their relationship to saliva production in community dwelling elderly: the SEE project. Salisbury Eye Evaluation. (1998) (75)
Concomitant therapy: an outcome variable for musculoskeletal disorders? Part 2: total joint replacement in osteoarthritis trials. (2001) (75)
Outcome measures and classification criteria for the rheumatic diseases. A compilation of data from OMERACT (Outcome Measures for Arthritis Clinical Trials), ILAR (International League of Associations for Rheumatology), regional leagues and other groups. (2001) (74)
The relation between bisphosphonate use and non-union of fractures of the humerus in older adults (2009) (74)
Connective tissue disease in southeastern Georgia: a case-control study of etiologic factors. (1989) (74)
Serum protein signatures detect early radiographic osteoarthritis. (2009) (74)
Alendronate Reduces the Risk of Multiple Symptomatic Fractures: Results from the Fracture Intervention Trial (2002) (73)
How useful are measures of BMD and bone turnover?* (2005) (73)
Development of clinical criteria for osteoarthritis. (1987) (72)
Serial pulmonary function in systemic sclerosis. (1982) (72)
Racial Differences in Bone Mineral Density in Older Men (2003) (72)
Clinical trial: the incidence of NSAID‐associated endoscopic gastric ulcers in patients treated with PN 400 (naproxen plus esomeprazole magnesium) vs. enteric‐coated naproxen alone (2010) (71)
Methodological problems in the epidemiological study of osteoarthritis. (1994) (71)
Factors associated with osteoarthritis of the hand in males: data from the Baltimore Longitudinal Study of Aging. (1991) (71)
Fractures after antiretroviral initiation (2012) (71)
New treatments for osteoarthritis (2013) (70)
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (2015) (70)
Bisphosphonates in the treatment of osteoporosis. (1997) (70)
Recreational physical activity and the risk of osteoarthritis of the hip in elderly women. (1999) (69)
The experience of pain and emergent osteoarthritis of the knee. (2001) (69)
The association of radiographic changes of osteoarthritis of the hand and hip in elderly women. (1995) (68)
Hip osteoarthritis prevalence estimates by three radiographic scoring systems. (1998) (68)
The contribution of osteoarthritis to disability: preliminary data from the Women's Health and Aging Study. (1995) (67)
Association of the G‐174C Variant in the Interleukin‐6 Promoter Region With Bone Loss and Fracture Risk in Older Women (2004) (66)
The comparative effectiveness of abatacept versus anti-tumour necrosis factor switching for rheumatoid arthritis patients previously treated with an anti-tumour necrosis factor (2013) (65)
Characterization of individual radiographic features of hip osteoarthritis in African American and White Women and Men: The Johnston County Osteoarthritis Project (2010) (65)
How do people with knee osteoarthritis use osteoarthritis pain medications and does this change over time? Data from the Osteoarthritis Initiative (2013) (65)
Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. (2006) (63)
Symptom and structure modification in osteoarthritis with pharmaceutical-grade chondroitin sulfate: what’s the evidence? (2013) (63)
Efficacy of traditional Chinese acupuncture in the treatment of symptomatic knee osteoarthritis: a pilot study. (1995) (63)
Preventing Fractures in Postmenopausal Women with Osteoporosis (2000) (62)
The natural history of emergent osteoarthritis of the knee in women. (2002) (62)
Infections requiring hospitalization in the abatacept clinical development program: an epidemiological assessment (2010) (62)
Nutritional supplements for knee osteoarthritis--still no resolution. (2006) (61)
Comparison of Weekly Treatment of Postmenopausal Osteoporosis with Alendronate Versus Risedronate Over Two Years (2006) (61)
Acetabular dysplasia and osteoarthritis of the hip in elderly white women (1997) (60)
Serum cartilage oligomeric matrix protein and clinical signs and symptoms of potential pre-radiographic hip and knee pathology. (2002) (60)
Hip Osteoarthritis and the Risk of All‐Cause and Disease‐Specific Mortality in Older Women: A Population‐Based Cohort Study (2015) (60)
A systematic review of randomized controlled trials of pharmacological therapy in osteoarthritis of the hip. (1997) (60)
Design and conduct of clinical trials in osteoarthritis: preliminary recommendations from a task force of the Osteoarthritis Research Society. (1997) (59)
Identification of an inherited form of Peyronie's disease with autosomal dominant inheritance and association with Dupuytren's contracture and histocompatibility B7 cross-reacting antigens. (1984) (59)
The OMERACT-OARSI Core Domain Set for Measurement in Clinical Trials of Hip and/or Knee Osteoarthritis (2019) (59)
OARSI Clinical Trials Recommendations: Design and conduct of clinical trials for hip osteoarthritis. (2015) (57)
Health of community-dwelling adults with mobility limitations in the United States: prevalent health conditions. Part I. (2008) (57)
Axial and hip bone mineral density and radiographic changes of osteoarthritis of the knee: data from the Baltimore Longitudinal Study of Aging. (1996) (57)
The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate . (2008) (56)
Tumor necrosis factor-alpha polymorphism, bone strength phenotypes, and the risk of fracture in older women. (2005) (56)
Controversies in COX-2 selective inhibition. (2002) (55)
Successful Skeletal Aging: A Marker of Low Fracture Risk and Longevity. The Study of Osteoporotic Fractures (SOF) (2009) (55)
Changes in proximal femoral mineral geometry precede the onset of radiographic hip osteoarthritis: The study of osteoporotic fractures. (2009) (55)
Appendicular bone mass and osteoarthritis of the hands in women: data from the Baltimore Longitudinal Study of Aging. (1994) (55)
The incidence and prevalence of extra-articular and systemic manifestations in a cohort of newly-diagnosed patients with rheumatoid arthritis between 1999 and 2006. (2008) (54)
Varus Thrust and Incident and Progressive Knee Osteoarthritis (2017) (53)
Collagenous colitis, enteropathic arthritis, and autoimmune diseases: results of a patient survey. (1989) (53)
Prevalence of systemic lupus erythematosus in England and Wales, 1981-2. (1987) (53)
Estrogen receptor alpha genotype is associated with a reduced prevalence of radiographic hip osteoarthritis in elderly Caucasian women. (2007) (53)
Putting evidence-based medicine into clinical practice: comparing anti-resorptive agents for the treatment of osteoporosis (2004) (53)
Clinically Relevant Outcomes Based on Analysis of Pooled Data from 2 Trials of Duloxetine in Patients with Knee Osteoarthritis (2012) (52)
The Relationship Between Caregiving and Mortality After Accounting for Time-Varying Caregiver Status and Addressing the Healthy Caregiver Hypothesis. (2015) (52)
Short- and long-term mortality in males and females with fragility hip fracture in Norway. A population-based study (2013) (52)
Fixed-dose combination of enteric-coated naproxen and immediate-release esomeprazole has comparable efficacy to celecoxib for knee osteoarthritis: two randomized trials (2011) (52)
Validity of self-reported rheumatoid arthritis in elderly women. (1996) (51)
Hip and non‐spine fracture risk reductions differ among antiresorptive agents: evidence from randomised controlled trials (2006) (51)
The history of lupus erythematosus. (1991) (51)
Management of osteoarthritis in older adults. (1998) (50)
Serum levels of insulin-like growth factor in subjects with osteoarthritis of the knee. Data from the Baltimore Longitudinal Study of Aging. (1994) (50)
Osteoarthritis year 2012 in review: clinical. (2012) (50)
Health of community-dwelling adults with mobility limitations in the United States: incidence of secondary health conditions. Part II. (2008) (50)
Association of blood lead concentrations with mortality in older women: a prospective cohort study (2009) (50)
Peyronie's disease: a newly recognized autosomal-dominant trait. (1982) (50)
Genome‐Wide Association Study of Radiographic Knee Osteoarthritis in North American Caucasians (2017) (50)
Lorecivivint, a Novel Intraarticular CDC‐like Kinase 2 and Dual‐Specificity Tyrosine Phosphorylation‐Regulated Kinase 1A Inhibitor and Wnt Pathway Modulator for the Treatment of Knee Osteoarthritis: A Phase II Randomized Trial (2020) (50)
Positive Affect and Incidence of Frailty in Elderly Women Caregivers and Noncaregivers: Results of Caregiver–Study of Osteoporotic Fractures (2009) (49)
Clinical algorithms to aid osteoarthritis guideline dissemination. (2016) (49)
Obesity and osteoarthritis of the hands in women. (1993) (49)
Epidemiology of osteoarthritis: current concepts and new insights. (1991) (48)
Epidemiologic considerations in the primary prevention of osteoarthritis. (1991) (48)
Impact of age-related macular degeneration on vision-specific quality of life: Follow-up from the 10-year and 15-year visits of the Study of Osteoporotic Fractures. (2010) (48)
Consensus statement on the relationship of breast implants to connective-tissue disorders. (1992) (48)
Genetic Variation in Candidate Osteoporosis Genes, Bone Mineral Density, and Fracture Risk: The Study of Osteoporotic Fractures (2008) (47)
Effect of alendronate for reducing fracture by FRAX score and femoral neck bone mineral density: The fracture intervention trial (2012) (47)
Metabolic correlates of obesity and radiographic features of knee osteoarthritis: data from the Baltimore Longitudinal Study of Aging. (1997) (46)
The association of augmentation mammoplasty with connective tissue disease, including systematic sclerosis (scleroderma): a meta-analysis. (1996) (46)
Incidence rates of fragility hip fracture in middle-aged and elderly men and women in southern Norway. (2012) (45)
Genetic epidemiology of osteoarthritis: recent developments and future directions (2013) (45)
A case-control study of serum tocopherol levels and the alpha- to gamma-tocopherol ratio in radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project. (2004) (45)
Hearing sensitivity and the risk of incident falls and fracture in older women: the study of osteoporotic fractures. (2004) (45)
Cross-reactive HLA antigens in B27-negative Reiter's syndrome and sacroiliitis. (1977) (45)
Gene expression profiling in peripheral blood mononuclear cells from lupus patients with active and inactive disease. (2004) (44)
Body mass index, weight change, and incidence of self-reported physician-diagnosed arthritis among women. (1999) (44)
New directions in symptomatic therapy for patients with osteoarthritis and rheumatoid arthritis. (2002) (44)
Osteoprotegerin Lys3Asn polymorphism and the risk of fracture in older women. (2008) (44)
Type I collagen alpha1 Sp1 transcription factor binding site polymorphism is associated with reduced risk of hip osteoarthritis defined by severe joint space narrowing in elderly women. (2005) (44)
Racial differences in the prevalence of vertebral fractures in older men: the Baltimore Men’s Osteoporosis Study (2005) (44)
Relationship of Blood Lead Levels to Incident Nonspine Fractures and Falls in Older Women: The Study of Osteoporotic Fractures (2008) (43)
Predictors of Short- and Long-Term Mortality in Males and Females with Hip Fracture - A Prospective Observational Cohort Study (2013) (43)
Erratum to: Incidence of malignancy in adult patients with rheumatoid arthritis: a meta-analysis (2016) (43)
COX-2 selective inhibitors in the treatment of arthritis: a rheumatologist perspective. (2005) (43)
Anti-Ro antibodies and neonatal lupus. (1989) (43)
Upper extremity bone mass and osteoarthritis of the knees: Data from the baltimore longitudinal study of aging (1995) (42)
The association of smoking and alcohol use with age-related macular degeneration in the oldest old: the Study of Osteoporotic Fractures. (2010) (42)
Osteoporosis in patients with rheumatic diseases. (1994) (42)
Racial differences in bone strength. (2007) (42)
Meaningful Improvement in Gait Speed in Hip Fracture Recovery (2011) (42)
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of location in the femorotibial joint: post-hoc analysis of a randomised, placebo-controlled phase II clinical trial (2020) (42)
Pharmacological therapy of osteoarthritis. (2001) (42)
The rate of decline of joint space width in patients with osteoarthritis of the knee: a systematic review and meta-analysis of randomized placebo-controlled trials of chondroitin sulfate* (2008) (41)
The Prevalence and Impact of Self-reported Hip Fracture in Elderly Community-Dwelling Women: The Women's Health and Aging Study (1998) (41)
The patterns and prevalence of hand osteoarthritis in a population of disabled older women: The Women's Health and Aging Study. (2000) (41)
Limited Clinical Utility of a Genetic Risk Score for the Prediction of Fracture Risk in Elderly Subjects (2015) (41)
Women with hip fracture have a greater rate of decline in bone mineral density than expected: another significant consequence of a common geriatric problem (2006) (41)
Session 2: clinical aspects. Clinical assessment of hand OA. (2000) (41)
Defining incident radiographic hip osteoarthritis for epidemiologic studies in women. (2009) (41)
The relationship of age and gender to prevalence and pattern of radiographic changes of osteoarthritis of the knee: Data from Caucasian participants in the Baltimore Longitudinal Study of Aging (1994) (40)
Systemic sclerosis (scleroderma): clinical, genetic, and serologic subsets. (1987) (40)
Dynamic Effects of Depressive Symptoms on Osteoarthritis Knee Pain (2018) (40)
Time-trends in gastroprotection with NSAIDs (2010) (39)
Associations between 25-hydroxyvitamin D and weight gain in elderly women. (2012) (39)
Height loss in older women: Risk of hip fracture and mortality independent of vertebral fractures (2012) (39)
Potential effects of chondroitin sulfate on joint swelling: a GAIT report. (2008) (39)
Efficacy and safety of naproxcinod in patients with osteoarthritis of the knee: a 53-week prospective randomized multicenter study. (2011) (38)
Clinical decisions in the use of acupuncture as an adjunctive therapy for osteoarthritis of the knee. (2001) (38)
FAMILY STUDIES IN HLA‐B27 ASSOCIATED ARTHRITIS (1978) (38)
Relationship between health status and utility measures in older claudicants (2004) (38)
Prognosis of osteoarthritis. (1996) (38)
Three-tiered-copayment drug coverage and use of nonsteroidal anti-inflammatory drugs. (2004) (37)
Clinical significance of worsening versus stable preradiographic MRI lesions in a cohort study of persons at higher risk for knee osteoarthritis (2015) (37)
The Minimum Clinically Important Improvement and Patient-acceptable Symptom State in the BASDAI and BASFI for Patients with Ankylosing Spondylitis (2016) (37)
Ethnic differences in self-reported functional status in the rural south: the Johnston County Osteoarthritis Project. (1996) (37)
Racial and ethnic differences in physical activity guidelines attainment among people at high risk of or having knee osteoarthritis (2013) (36)
Analysis of the effect of COX-2 specific inhibitors and recommendations for their use in clinical practice. (2000) (36)
DXA-based hip structural analysis of once-weekly bisphosphonate-treated postmenopausal women with low bone mass (2009) (36)
The accuracy of self-report of physician diagnosed rheumatoid arthritis in moderately to severely disabled older women. Women's Health and Aging Collaborative Research Group. (2000) (36)
COX-2-selective inhibitors in the treatment of arthritis. (2002) (35)
Response to expression of concern regarding VIGOR study. (2006) (35)
Role of intra-articular hyaluronic acid preparations in medical management of osteoarthritis of the knee. (2000) (35)
Caregiving, Metabolic Syndrome Indicators, and 1-year Decline in Walking Speed: Results of Caregiver-SOF (2010) (35)
Weight Loss and Exercise Walking Reduce Pain and Improve Physical Functioning in Overweight Postmenopausal Women with Knee Osteoarthritis (2001) (35)
Early aggressive DMARD therapy: the key to slowing disease progression in rheumatoid arthritis. (1999) (34)
Visual Field Loss and Risk of Fractures in Older Women (2009) (34)
The presence of Campylobacter pylori in nonsteroidal antiinflammatory drug associated gastritis. (1989) (34)
Fetal wastage in women with anti-Ro(SSA) antibody. (1986) (34)
Absence of association of asporin polymorphisms and osteoarthritis susceptibility in US Caucasians. (2008) (34)
HIV infection is not associated with Reiter's syndrome: data from the Johns Hopkins Multicenter AIDS Cohort Study. (1990) (34)
A reference case for economic evaluations in osteoarthritis: an expert consensus article from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO). (2014) (33)
A Phase 2b Randomized Trial of Lorecivivint, a Novel Intra-articular CLK2/DYRK1A Inhibitor and Wnt Pathway Modulator for Knee Osteoarthritis. (2021) (33)
Smoking, Smoking Cessation, and Disease Activity in a Large Cohort of Patients with Rheumatoid Arthritis (2012) (33)
Auranofin or D-penicillamine in the treatment of rheumatoid arthritis. (1986) (33)
Alignment of the medial tibial plateau affects the rate of joint space narrowing in the osteoarthritic knee. (2010) (33)
Why is the concept of spondyloarthropathies important? (2002) (32)
Running does not increase symptoms or structural progression in people with knee osteoarthritis: data from the osteoarthritis initiative (2018) (32)
Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study (2014) (32)
Homozygosity For HLA‐B27 (1977) (31)
Is There an Association Between a History of Running and Symptomatic Knee Osteoarthritis? A Cross‐Sectional Study From the Osteoarthritis Initiative (2017) (31)
Drug Insight: choosing a drug treatment strategy for women with osteoporosis—an evidence-based clinical perspective (2008) (31)
Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Biomarkers and Frailty (2015) (31)
Serum carotenoids and radiographic knee osteoarthritis: the Johnston County Osteoarthritis Project (2001) (30)
What a difference a year makes: Reflections on the ACR recommendations for the medical management of osteoarthritis (2001) (30)
Estrogen replacement therapy and incidence of self-reported physician-diagnosed arthritis. (1999) (30)
Osteoarthritis of the knee (1997) (30)
“Stepping-up” from methotrexate: a systematic review of randomised placebo controlled trials in patients with rheumatoid arthritis with an incomplete response to methotrexate (2001) (30)
Estrogen receptor alpha and matrix metalloproteinase 2 polymorphisms and age-related maculopathy in older women. (2008) (30)
Responsiveness of the Intermittent and Constant Osteoarthritis Pain (ICOAP) scale in a trial of duloxetine for treatment of osteoarthritis knee pain. (2013) (29)
Severity of radiographic findings in hip osteoarthritis associated with total hip arthroplasty. (1996) (29)
Association Analysis of BMD‐associated SNPs with Knee Osteoarthritis (2014) (29)
Erratum to: Can We Identify Patients with High Risk of Osteoarthritis Progression Who Will Respond to Treatment? A Focus on Epidemiology and Phenotype of Osteoarthritis (2017) (29)
Osteoporosis and Osteoarthritis, Rheumatoid Arthritis and Spondylarthropathies (2013) (29)
An approach to developing criteria for the clinical diagnosis and classification of osteoarthritis: a status report of the American Rheumatism Association Diagnostic Subcommittee on Osteoarthritis. (1983) (29)
Glucosamine therapy for treating osteoarthritis (Review) (2005) (29)
Changes in bone mineral density over time by body mass index in the health ABC study (2016) (29)
Joint-specific hand symptoms and self-reported and performance-based functional status in African–Americans and Caucasians: The Johnston County Osteoarthritis Project (2007) (29)
Low bone mineral density is a significant risk factor for low-energy distal radius fractures in middle-aged and elderly men: A case-control study (2011) (28)
Immunosuppressive treatment and the risk of diabetes in rheumatoid arthritis (2019) (28)
Lorecivivint, a Novel Intra-articular CLK/DYRK1A Inhibitor and Wnt Pathway Modulator for Treatment of Knee Osteoarthritis: A Phase 2 Randomized Trial. (2020) (28)
The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis. (1989) (28)
Symptom Assessment in Knee Osteoarthritis Needs to Account for Physical Activity Level (2015) (27)
Periarticular bone predicts knee osteoarthritis progression: Data from the Osteoarthritis Initiative. (2018) (27)
Long‐Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial (2021) (27)
Gastrointestinal side effects in postmenopausal women using osteoporosis therapy: 1-year findings in the POSSIBLE US study (2010) (27)
Comparison of different methods of classifying patients with systemic lupus erythematosus. (1991) (26)
Short-term changes in body composition after surgical repair of hip fracture. (2014) (26)
Interleukin 1 receptor antagonist (IL1RN) gene variants predict radiographic severity of knee osteoarthritis and risk of incident disease (2019) (26)
Association of nonsteroidal antiinflammatory drugs with upper gastrointestinal disease: epidemiologic and economic considerations. (1992) (26)
A fixed-dose combination of naproxen and esomeprazole magnesium has comparable upper gastrointestinal tolerability to celecoxib in patients with osteoarthritis of the knee: Results from two randomized, parallel-group, placebo-controlled trials (2011) (25)
Results from a 52-week randomized, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular wnt pathway inhibitor (SM04690) for the treatment of knee osteoarthritis (2018) (25)
Knee tissue lesions and prediction of incident knee osteoarthritis over 7 years in a cohort of persons at higher risk. (2017) (25)
Disease modification in osteoarthritis; pathways to drug approval (2020) (25)
Do risk factors for incident hip osteoarthritis (OA) differ from those for progression of hip OA? (2004) (24)
Meniscal tear and extrusion are strongly associated with the progression of knee osteoarthritis as assessed by quantitative magnetic resonance (2004) (24)
Treatment of osteoarthritis with acetaminophen: Efficacy, safety, and comparison with nonsteroidal anti-inflammatory drugs (2000) (24)
Association of the VDR Translation Start Site Polymorphism and Fracture Risk in Older Women (2007) (24)
Abdominal aortic calcification and risk of fracture among older women - The SOF study. (2015) (24)
The potential value of monitoring bone turnover markers among women on alendronate (2012) (24)
Comparative risk of malignancies and infections in patients with rheumatoid arthritis initiating abatacept versus other biologics: a multi-database real-world study (2019) (24)
Efficacy and safety of low-dose SoluMatrix meloxicam in the treatment of osteoarthritis pain: a 12-week, phase 3 study (2015) (24)
Predicting the prognosis of patients with rheumatoid arthritis: is there a crystal ball? (1993) (23)
Factors associated with the orthopaedic surgeon's decision to recommend total joint replacement in hip and knee osteoarthritis: an international cross-sectional study of 1905 patients. (2018) (23)
Bromide intoxication. (1976) (23)
Long-term structural and symptomatic effects of intra-articular sprifermin in patients with knee osteoarthritis: 5-year results from the FORWARD study (2021) (23)
Sedentary behavior and blood pressure control among osteoarthritis initiative participants. (2014) (23)
What have we learned from the large outcomes trials of COX-2 selective inhibitors? The rheumatologist's perspective. (2001) (23)
The impact of body composition, pain and resilience on physical activity, physical function and physical performance at 2 months post hip fracture. (2018) (23)
Are psychosocial factors related to response to acupuncture among patients with knee osteoarthritis? (1999) (23)
Classification Algorithms for Hip Fracture Prediction Based on Recursive Partitioning Methods (2004) (22)
The role of acetaminophen in the management of patients with osteoarthritis. (2001) (22)
Visual Acuity, Contrast Sensitivity, and Mortality in Older Women: Study of Osteoporotic Fractures (2002) (22)
Depressive symptoms and structural disease progression in knee osteoarthritis: data from the Osteoarthritis Initiative (2016) (21)
Management of osteoarthritis (2015) (21)
The prevalence and incidence of juvenile rheumatoid arthritis in an urban Black population. (1983) (21)
Rheumatic and musculoskeletal diseases and impaired quality of life: a challenge for rheumatologists. (1996) (21)
Women with hip fracture experience greater loss of geometric strength in the contralateral hip during the year following fracture than age-matched controls (2010) (21)
Mortality from systemic lupus erythematosus in England and Wales, 1974-1983. (1987) (21)
Higher serum concentrations of dietary antioxidants are associated with lower levels of inflammatory biomarkers during the year after hip fracture. (2012) (21)
Surgical menopause and nonvertebral fracture risk among older US women (2012) (20)
The effects of sprifermin on symptoms and structure in a subgroup at risk of progression in the FORWARD knee osteoarthritis trial. (2021) (20)
Multidisciplinary Integrative Approach to Treating Knee Pain in Patients with Osteoarthritis (2003) (20)
Current Models for Development of Disease-Modifying Osteoarthritis Drugs. (2021) (20)
Osteoporosis in men: update 2011. (2011) (20)
Age‐Related Macular Degeneration and Mortality in Older Women: The Study of Osteoporotic Fractures (2015) (19)
Cosmetic Surgical Procedures and Connective Tissue Disease: The Cleopatra Syndrome Revisited (1993) (19)
Frequency of augmentation mammoplasty in patients with systemic sclerosis: data from the Johns Hopkins-University of Maryland Scleroderma Center. (1995) (18)
HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis (1987) (18)
Connective tissue disease in southeast Georgia. A community based study of immunogenetic markers and autoantibodies. (1990) (18)
Cognitive Differences between Men and Women who Fracture their Hip and Impact on Six‐Month Survival (2017) (18)
Novel methods to evaluate fracture risk models (2011) (18)
Reliability and validity of abbreviated surveys derived from the National Eye Institute Visual Function Questionnaire: the study of osteoporotic fractures. (2010) (18)
Comments on the discordant recommendations for the use of symptomatic slow-acting drugs in knee osteoarthritis (2015) (18)
Harmonising measures of knee and hip osteoarthritis in population-based cohort studies: an international study. (2018) (18)
Coxibs and NSAIDs--is the air any clearer? Perspectives from the OARSI/International COX-2 Study Group Workshop 2007. (2007) (18)
Huo-Luo-Xiao-Ling (HLXL)-Dan, a Traditional Chinese Medicine, for patients with osteoarthritis of the knee: a multi-site, randomized, double-blind, placebo-controlled phase II clinical trial. (2015) (17)
Abatacept for the treatment of adults with psoriatic arthritis: patient selection and perspectives (2018) (17)
Self-ratings of health and change in walking speed over 2 years: results from the caregiver-study of osteoporotic fractures. (2011) (17)
Meta‐Analysis of Assay Sensitivity and Study Features in Clinical Trials of Pharmacologic Treatments for Osteoarthritis Pain (2014) (17)
Epidemiology and genetics of ankylosing spondylitis. (1988) (17)
Effects of Prefracture Depressive Illness and Postfracture Depressive Symptoms on Physical Performance After Hip Fracture (2016) (17)
Accuracy of self‐reported diagnosis of hip replacement (2010) (17)
Genetics of osteoarthritis (2004) (16)
One Hour a Week: Moving to Prevent Disability in Adults With Lower Extremity Joint Symptoms. (2019) (16)
Treatment of rheumatoid arthritis and osteoarthritis with COX-2-selective inhibitors: a managed care perspective. (2002) (15)
Introduction to OARSI FDA initiative OAC special edition. (2011) (15)
Quality measures in osteoarthritis. (2007) (15)
Uptake of the OMERACT-OARSI Hip and Knee Osteoarthritis Core Outcome Set: Review of Randomized Controlled Trials from 1997 to 2017 (2019) (15)
Epidemiology and genetics of osteoarthritis (1991) (15)
Prevention and Management of Gout (1993) (15)
Pain severity as a mediator of the association between depressive symptoms and physical performance in knee osteoarthritis. (2018) (15)
Differences in the trajectory of bone mineral density change measured at the total hip and femoral neck between men and women following hip fracture (2016) (14)
New paradigms in the management of osteoarthritis patients with hypertension. (2010) (14)
Severity of hand osteoarthritis and its association with upper extremity impairment in a population of disabled older women: The Women’s Health and Aging Study (1999) (14)
Part 2: Treatment Approaches (2015) (14)
Association of nitrate use with risk of new radiographic features of hip osteoarthritis in elderly white women: the study of osteoporotic fractures. (2003) (14)
COX-2: Where are we in 2003? - Be strong and resolute: continue to use COX-2 selective inhibitors at recommended dosages in appropriate patients (2002) (14)
Silicone breast implants and rheumatic disease. (1994) (14)
Proceedings of the Eighth Annual Santa Fe Bone Symposium, August 3-4, 2007. (2008) (14)
Reading and interpreting economic evaluations in rheumatoid arthritis: an assessment of selected instruments for critical appraisal. (2003) (14)
In normal knees, joint space width (JSW) is correlated with the intermargin distance (IMD), a measure of medial tibial plateau alignment. Variations in IMD explain variability in JSW in serial radiographs. (2013) (14)
Osteoarthritis: pathophysiology, clinical features, management. (1984) (13)
Efficacy and safety from a phase 2B trial of SM04690, a novel, intra-articular, WNT pathway inhibitor for the treatment of osteoarthritis of the knee (2019) (13)
OP0059 Efficacy and safety of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomised, placebo-controlled, phase ii study (2018) (13)
Glucocorticoid-induced osteoporosis in men. (2011) (13)
Seminars in Arthritis and Rheumatism: An Update (2010) (13)
Acute leukemia following cyclophosphamide therapy for Sjögren's syndrome. (1978) (13)
Examining Differences in Recovery Outcomes between Male and Female Hip Fracture Patients: Design and Baseline Results of A Prospective Cohort Study from the Baltimore Hip Studies (2018) (13)
Platelet inhibitory effects of OTC doses of naproxen sodium compared with prescription dose naproxen sodium and low-dose aspirin (2009) (13)
HLA-C locus antigens in HLA-B27 associated arthritis. (1978) (13)
Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis (2013) (13)
Residual Disability, Mortality, and Nursing Home Placement After Hip Fracture Over 2 Decades. (2019) (12)
Genetic Determinants of Radiographic Knee Osteoarthritis in African Americans (2017) (12)
Osteoarthritis: definitions and criteria. (1990) (12)
Effect of maximum OTC doses of naproxen sodium or acetaminophen on low-dose aspirin inhibition of serum thromboxane B2 (2010) (12)
Depression Subtypes in Individuals With or at Risk for Symptomatic Knee Osteoarthritis (2020) (12)
Secondary Fracture Prevention: Consensus Clinical Recommendations From a Multistakeholder Coalition. (2020) (12)
Development and progression of osteoarthritis. (1996) (12)
HLA-DR4 and pulmonary dysfunction in rheumatoid arthritis. (1987) (12)
The utility of changes in serum levels of C-terminal telopeptide of type I collagen in predicting patient response to oral monthly ibandronate therapy. (2010) (12)
Antibodies to denatured type II collagen in rheumatoid arthritis: negative association with IgM rheumatoid factor. (1990) (11)
Persistence of depressive symptoms and gait speed recovery in older adults after hip fracture (2018) (11)
Clinical features of systemic lupus erythematosus. (1993) (11)
Physical properties of tetra-n-alkylgermanes (C1-C6) (1974) (11)
Serum vitamin E concentrations and recovery of physical function during the year after hip fracture. (2011) (11)
Significance of pre-radiographic mri lesions in persons at higher risk for knee osteoarthritis (2014) (11)
Prescribed regimen is effective (2010) (11)
Evaluating the structural effects of intra-articular sprifermin on cartilage and non-cartilaginous tissue alterations, based on sqMRI assessment over two years. (2020) (11)
Genotype, resilience and function and physical activity post hip fracture. (2019) (10)
Degenerative joint disease. (1983) (10)
A Phase 2 Study of Lower-dose, Indomethacin Submicron Particle Capsules Demonstrates Early Onset of Acute Pain Relief (2014) (10)
OP0010 CARTILAGE THICKNESS MODIFICATION WITH SPRIFERMIN IN KNEE OSTEOARTHRITIS PATIENTS TRANSLATES INTO SYMPTOMATIC IMPROVEMENT OVER PLACEBO IN PATIENTS AT RISK OF FURTHER STRUCTURAL AND SYMPTOMATIC PROGRESSION: POST-HOC ANALYSIS OF THE PHASE II FORWARD TRIAL (2019) (10)
Serum vitamin E concentrations among highly functioning hip fracture patients are higher than in nonfracture controls. (2011) (10)
Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study (2015) (10)
A Case-Control Study of Serum Tocopherol Levels and the Alpha- to Gamma- Tocopherol Ratio in Radiographic Knee Osteoarthritis (2004) (10)
THU0458 EFFICACY AND SAFETY FROM A PHASE 2B TRIAL OF SM04690, A NOVEL INTRA-ARTICULAR WNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE (2019) (10)
The Study of Osteoporotic Fractures: Major Findings and Contributions (2008) (10)
Effect size is encouraging (2010) (10)
Accuracy of creatinine clearance in measuring glomerular filtration rate in patients with systemic lupus erythematosus without clinical evidence of renal disease. (1990) (10)
Epidemiology of rheumatoid arthritis in developed countries. (1983) (10)
Difference in the trajectory of change in bone geometry as measured by hip structural analysis in the narrow neck, intertrochanteric region, and femoral shaft between men and women following hip fracture. (2016) (10)
Prevention of lower limb osteoarthritis: Data from the Johns Hopkins Precursors Study (2002) (9)
Etanercept for the treatment of rheumatoid arthritis. (2003) (9)
Bone Mineral Density and Age‐Related Maculopathy in Older Women (2007) (9)
Proposed 2011 American College of Rheumatology Recommendations for the Use of Non-pharmacologic and Pharmacologic Therapies in Osteoarthritis of the Hand, Hip and Knee (2011) (9)
Erratum: Fracture risk reduction with alendronate in women with osteoporosis: The fracture intervention trial (Journal of Clinical Endocrinology and Metabolism, 85 (4118-4124)) (2001) (9)
Malignancy validation in a United States registry of rheumatoid arthritis patients (2012) (9)
Nonvertebral fracture risk reduction with nitrogen-containing bisphosphonates (2008) (9)
Association between disease progression and depression onset in persons with radiographic knee osteoarthritis. (2020) (9)
Lorecivivint, an intra-articular potential disease-modifying osteoarthritis drug (2020) (9)
A model for time to fracture with a shock stream superimposed on progressive degradation: the Study of Osteoporotic Fractures (2015) (9)
Older men who sustain a hip fracture experience greater declines in bone mineral density at the contralateral hip than non-fractured comparators (2018) (9)
Serum 25(OH)D is associated with an altered bone turnover marker response after a hip fracture (2019) (8)
Evaluation of clinically relevant changes and states in symptomatic outcome variables in osteoarthritis of the lower limbs (2003) (8)
34 LOW SELENIUM LEVELS ARE ASSOCIATED WITH INCREASED ODDS OF RADIOGRAPHIC HIP OSTEOARTHRITIS IN AFRICAN AMERICAN AND WHITE WOMEN (2007) (8)
Acute monoarthritis: a practical approach to assessment and treatment. (1996) (8)
Homozygosity for HLA-B27. Impact on rheumatic disease expression in two families. (1977) (8)
Comparing Longitudinal Sarcopenia Trends by Definitions Across Men and Women After Hip Fracture (2020) (8)
Prevention and management of glucocorticoid-induced osteoporosis. (1995) (8)
Safety of Abatacept Versus Placebo in Rheumatoid Arthritis: Integrated Data Analysis of Nine Clinical Trials (2019) (8)
Assessing Population Risk for Postmenopausal Osteoporosis: A New Strategy Using Data From the Behavioral Risk Factor Surveillance System (BRFSS) (2007) (8)
Predicting knee replacement in participants eligible for disease-modifying osteoarthritis drug treatment with structural endpoints. (2020) (7)
38 COST EFFECTIVENESS OF TRADITIONAL CHINESE ACUPUNCTURE AS ADJUNCTIVE THERAPY IN OSTEOARTHRITIS OF THE KNEE (2007) (7)
Quantitative radiography in osteoarthritis: analysis. (1996) (7)
Identifying factors associated with concordance with the American College of Rheumatology rheumatoid arthritis treatment recommendations (2016) (7)
Genome-wide meta-analysis identified novel variant associated with hallux valgus in Caucasians (2020) (7)
SAT0165 The effect of alendronate on age-specific incidence of key osteoporotic fractures (2001) (7)
Prevalence, Incidence, and Progression of Radiographic and Symptomatic Hand Osteoarthritis: The Osteoarthritis Initiative (2022) (7)
Glucosamine therapy for treating osteoarthritis. (2001) (7)
Intra-articular Corticosteroid Injections in the Hip and Knee: Perhaps Not as Dangerous as They Want You to Believe? (2020) (7)
Long-term experience with alendronate in the treatment of osteoporosis (2006) (7)
Asymmetry in CT Scan Measures of Thigh Muscle 2 Months After Hip Fracture: The Baltimore Hip Studies. (2015) (6)
In vitro suppression of anti-DNA antibody and immunoglobulin synthesis in systemic lupus erythematosus patients by human gamma interferon. (1988) (6)
Classification criteria for childhood arthritic diseases. (1995) (6)
The cross-sectional relationship of hemoglobin levels and functional outcomes in women with self-reported osteoarthritis: results from the Women's Health Initiative. (2011) (6)
Identification of pain categories associated with change in pain in patients receiving placebo: data from two phase 3 randomized clinical trials in symptomatic knee osteoarthritis (2018) (6)
Acupuncture for osteoarthritis (1998) (6)
Postmenopausal Hormone Therapy and Age-Related Maculopathy in Older Women (2008) (6)
Recommendations for measurement of bone mineral density and identifying persons to be treated for osteoporosis. (2006) (6)
Clinical practice guidelines for osteoarthritis (2013) (6)
Development and implementation of an immunization program for patients with rheumatoid arthritis. (1989) (6)
Overview of the inflammatory vascular diseases (2003) (6)
OP0061 Treatment of knee osteoarthritis with sm04690 improved womac a1 ‘pain on walking’ – results from a 52 week, randomised, double-blind, placebo-controlled, phase 2 study of a novel, intra-articular, wnt pathway inhibitor (2018) (5)
Challenges in ameliorating hunger while preventing obesity (2012) (5)
Opportunities for the prevention of osteoarthritis. (2010) (5)
Randomized, double-blind, multicenter, non inferiority clinical trial with combined glucosamine and chondroitin sulfate vs celecoxib for painful knee osteoarthritis (2014) (5)
Osteoarthritis susceptibility genes continue trickling in (2012) (5)
Validation of a new symptom outcome for knee osteoarthritis: the Ambulation Adjusted Score for Knee pain (2018) (5)
Quality of life and radiographic severity of knee osteoarthritis predict total knee arthroplasty: data from the osteoarthritis initiative (2013) (5)
Secondary Fracture Prevention: Consensus Clinical Recommendations from a Multistakeholder Coalition. (2020) (5)
The absence of back pain in classical ankylosing spondylitis. (1978) (5)
Rofecoxib and clinically significant gastrointestinal events. (2011) (5)
OP0188 INTEGRATED SAFETY SUMMARY OF THE NOVEL, INTRA-ARTICULAR AGENT LORECIVIVINT (SM04690), A CLK/DYRK1A INHIBITOR THAT MODULATES THE WNT PATHWAY, IN SUBJECTS WITH KNEE OSTEOARTHRITIS (2020) (5)
Fetal viral myocarditis and congenital complete heart block in a pregnancy complicated by systemic lupus erythematosus. A case report. (1987) (5)
Controversies in COX-2 inhibitor therapy: closing remarks. (2001) (5)
CHAPTER 2 – Descriptive Epidemiology of Rheumatoid Arthritis (2009) (5)
Precision medicine in osteoarthritis: not yet ready for prime time (2020) (5)
Risk factors for the development and progression of hip osteoarthritis. (2005) (5)
P96 EFFECT OF OVER-THE-COUNTER DOSES OF NAPROXEN SODIUM ON INHIBITION OF PLATELET CYCLOOXYGENASE-1 IN HEALTHY VOLUNTEERS (2006) (5)
SAT0336 The Long-Term Effects of Sysadoa Treatment on Knee Osteoarthritis Symptoms and Progression of Structural Changes: Participants from the Osteoarthritis Initiative Progression Cohort (2013) (5)
The American Viewpoint (1999) (5)
An epidemiological approach to the study of outcome in rheumatoid arthritis. (1992) (5)
OP0161 Use of TNF Inhibitors is Associated with a Reduced Risk of Diabetes in RA Patients (2013) (5)
Cox‐2 Inhibitors and Fracture Healing: An Argument Against Such an Effect (2003) (5)
Long-term efficacy and safety of intra-articular sprifermin in patients with knee osteoarthritis: results from the 5-year forward study (2020) (5)
Pain, Genes, and Function in the Post-Hip Fracture Period. (2016) (4)
Systemic lupus erythematosus VIII: Prognosis. (1984) (4)
SAT0427 Multicentric Osteoarthritis Intervention Study with Sysadoa (MOVES): Effects of Combined Glucosamine Hydrochloride and Chondroitin Sulfate VS Celecoxib for Painful Knee Osteoarthritis (2014) (4)
Seminars in Arthritis and Rheumatism enters a new decade. (2010) (4)
Football Increases Future Risk for Symptomatic Radiographic Knee Osteoarthritis. (2020) (4)
A48 GENOME-WIDE LINKAGE SCAN AND HIGH-DENSITY ASSOCIATION STUDIES IMPLICATE CHROMOSOME 18q21 WITH GENERALIZED OSTEOARTHRITIS (2008) (4)
Did COVID-19 impact osteoarthritis – clinical perspective? (2021) (4)
Prolonged exposure to subcutaneous and intravenous abatacept in patients with rheumatoid arthritis does not affect rates of infection, malignancy and autoimmune events: results from pooled clinical trial data (2013) (4)
HLA-DQw alloantigens and pulmonary dysfunction in rheumatoid arthritis. (1988) (4)
Lower-dose diclofenac capsules developed using solumatrix fine particle technology result in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis (2014) (4)
Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort (2013) (4)
Frequency of Varus and Valgus Thrust and Factors Associated with Thrust Presence in Persons With or at Higher Risk for Knee Osteoarthritis (2011) (4)
Sex Differences in Recovery Across Multiple Domains among Older Adults with Hip Fracture. (2021) (4)
Monozygotic twins discordant for polymyalgia rheumatica. (1982) (4)
Development and validation of risk stratification trees for incident slow gait speed in persons at high risk for knee osteoarthritis (2019) (4)
SAT0586 Results from a 52 week randomised, double-blind, placebo-controlled, phase 2 study of a novel, wnt pathway inhibitor (SM04690) for knee osteoarthritis treatment (2018) (4)
CHARACTERIZATION OF THE CLASS I HLA 9.2‐kb PVU II RESTRICTION FRAGMENT LENGTH POLYMORPHISM: Linkage to HLA‐A and Lack of Disease Association (1989) (4)
[Epidemiology of knee osteoarthritis: results of the longitudinal study of Baltimore on the aging]. (1996) (4)
Intra-articular sprifermin reduces cartilage loss in addition to increasing cartilage gain independent of femorotibial location: a post-hoc analysis of a randomized, placebo-controlled phase ii clinical trial (2018) (3)
Comment on the article by Hernandez-Avila et al. (1991) (3)
OP0226 SOLID TUMOUR OUTCOMES IN PATIENTS WITH RA TREATED WITH ABATACEPT AND OTHER DMARDS: RESULTS FROM A 10-YEAR INTERNATIONAL POST-APPROVAL STUDY (2019) (3)
Non-surgical management of hip and knee osteoarthritis; comparison of ACR/AF and OARSI 2019 and VA/DoD 2020 guidelines (2021) (3)
Soluble Tumor Necrosis Factor Alpha Receptor 1, Bone Resorption, and Bone Mineral Density in the Year Following Hip Fractures: The Baltimore Hip Studies (2018) (3)
PN400 Significantly Improves Upper Gastrointestinal Tolerability Compared with Enteric-Coated Naproxen Alone in Patients Requiring Chronic NSAID Therapy: Results from Two Prospective, Randomized, Controlled Trials: 126 (2009) (3)
Asymmetry in CT Scan Measures of Thigh Muscle 2 Months After Hip Fracture: The Baltimore Hip Studies. (2015) (3)
CHAPTER 3C – Risk Factors for Rheumatoid Arthritis: Other Nongenetic Host Factors (2009) (3)
Osteoporosis Medication Use: A Comparison of Elderly Females Living in Long-term Care Facilities Versus Community Dwellers. (2019) (3)
A Phase 3 study of lower-dose diclofenac submicron particle capsules demonstrates effective pain relief in patients with osteoarthritis (2013) (3)
Contribution of Common Genetic Variants to Risk of Early-Onset Ischemic Stroke (2022) (3)
Medical overuse of therapies and diagnostics in rheumatology (2021) (3)
Management of hand osteoarthritis: from an US evidence-based medicine guideline to a European patient-centric approach (2022) (3)
Validation of a quantification imaging system for the normal and osteoarthritic knee (2001) (3)
Medical management of osteoarthritis. (1995) (3)
Systemic lupus erythematosus epidemiology and genetics. (1983) (3)
Trunk Muscle Composition 2 Months After Hip Fracture: Findings From the Baltimore Hip Studies. (2019) (3)
Familial resemblance and shared latent familial variance in recurrent fall risk in older women. (2010) (3)
SAT0233 Comparison of Abatacept and Other Biologic DMARDS for the Treatment of Rheumatoid Arthritis Patients: A Systematic Literature Review and Network Meta-Analysis (2014) (3)
Measuring the variation between self-reported osteoarthritis pain assessments (2016) (3)
Autoimmune disease and histocompatibility antigen. (1977) (3)
Update of proceedings of the 2002 International Workshop on Osteoarthritis Outcomes (2005) (3)
Corrigendum to “OARSI Clinical Trials Recommendations: design and conduct of clinical trials for hip osteoarthritis” [Osteoarthritis Cartilage 23 (2015) 761–771] (2015) (3)
Screening for osteoporosis in men: comment on the American College of Physicians clinical guidelines (2008) (3)
Efficacy and safety of intra-articular Sprifermin in symptomatic radiographic knee osteoarthritis: pre-specified analysis of 3-year data from a 5-year randomized, placebo-controlled, phase II study (2018) (3)
Unconventional Views of Frailty Frailty and Risk of Falls , Fracture , and Mortality in Older Women : The Study of Osteoporotic Fractures (2007) (2)
Efficacy and safety of s201086/GLPG1972, an ADAMTS-5 inhibitor, in patients with knee osteoarthritis: roccella, a 52-week, randomized, double-blind, dose-ranging phase 2 study (2021) (2)
What is the predictive value of MRI for the occurrence of hard clinical endpoints in knee osteoarthritis (2013) (2)
WITHDRAWN: Analgesia and non-aspirin, non-steroidal anti-inflammatory drugs for osteoarthritis of the hip. (2007) (2)
Colitic arthritis. (1982) (2)
Gardening associates with less knee pain: data from the osteoarthritis initiative (2018) (2)
2 OARSI TREATMENT GUIDELINES FOR HIP AND KNEE OSTEOARTHRITIS (2006) (2)
OMERACT-OARSI Initiative: OARSI set of responder criteria for osteoarthritis (OA) clinical trials revisited (2002) (2)
Serum levels of vitamin D and parathyroid hormone and progression of knee OA: the osteoarthritis initiative study (2013) (2)
Genetic association analysis of radiographic hip osteoarthritis with established loci for bone mineral density: data from the osteoarthritis initiative (2014) (2)
Comprar Rheumatology Online | Marc C. Hochberg | 9780323044301 | Mosby (2007) (2)
FRI0538 Structural effects of intra-articular sprifermin in symptomatic radiographic knee osteoarthritis: a post-hoc analysis of cartilage and non-cartilaginous tissue alterations of the 2-year data from a 5-year randomised, placebo-controlled, phase ii study (2018) (2)
Response to: ‘Is chondroitin sulfate plus glucosamine superior to placebo in the treatment of knee osteoarthritis?’ by Zeng et al (2015) (2)
Comparison of intra-articular sham and vehicle injection from a phase 2b trial of SM04690, a small-molecule Wnt inhibitor, for knee osteoarthritis (2019) (2)
Relationship Between Depression and Disease Activity in United States Veterans With Early Rheumatoid Arthritis Receiving Methotrexate (2020) (2)
Use of fracture history to predict long term risk of specific fracture types: Is any non-vertebral fracture history an adequate predictor? (2009) (2)
Weight loss for overweight patients with knee or hip osteoarthritis (2017) (2)
Risk Factors for Facial Pain: Data from the Osteoarthritis Initiative Study (2017) (2)
FDA/Arthritis Foundation osteoarthritis drug development workshop recap: Assessment of long-term benefit. (2022) (2)
Neurocognitive measures predict voluntary stepping performance in older adults post-hip fracture. (2020) (2)
Association Between Walking for Exercise and Symptomatic and Structural Progression in Individuals With Knee Osteoarthritis: Data From the Osteoarthritis Initiative Cohort (2022) (2)
Original article Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study (2014) (2)
2 – Collagen—vascular disease and disability (1985) (2)
Features assessed on magnetic resonance images improve prediction of total knee arthroplasty in subjects with symptomatic radiographic knee osteoarthritis: data from the osteoarthritis initiative (2014) (2)
Low-dose solumatrix meloxicam demonstrates low systemic exposure and efficacy in patients with osteoarthitis pain in clinical studies (2015) (2)
Long‐term sex differences in all‐cause and infection‐specific mortality post hip fracture (2022) (2)
Combined chondroitin sulfate and Glucosamine versus celecoxib for painful Knee osteoarthritis: post-hoc analyses by Kellgren and Lawrence grade and C-reactive protein level from a randomized, double-blind, multicentre clinical trial (2015) (2)
OP0265 Mortality after fragility hip fracture in middle aged and elderly men and women in southern norway (2013) (1)
Genome-wide association study of knee bone marrow lesions and association with previously reported bone mineral density loci (2016) (1)
Chapter 18Arthritis and Other Musculoskeletal Diseases (2010) (1)
284 THE USE OF CLASSIFICATION TREES TO DETERMINE CRITERIA FOR ‘VIRTUAL TOTAL JOINT REPLACEMENT’ FOR PATIENTS WITH HIP AND KNEE OSTEOARTHRITIS (2011) (1)
Depressive symptom heterogeneity among older adults after hip fracture. (2021) (1)
Differences in evidence‐based osteoporosis medication use between elderly men and women enrolled in Medicare Part D (2019) (1)
Rheumatoid arthritis XII: epidemiology and genetics. (1983) (1)
Evidence that Swimming May Be Protective of Knee Osteoarthritis: Data from the Osteoarthritis Initiative (2020) (1)
Differential misclassification of cognitive impairment by sex among hip fracture patients (2021) (1)
408 SAFETY AND EFFICACY OF HUO-LUO-XIAO-LING (HLXL) DAN IN OSTEOARTHRITIS OF THE KNEE (2007) (1)
We should treat pain (2013) (1)
Prescription glucosamine sulphate is effective in knee osteoarthritis (2018) (1)
FRI0118 INFECTION OUTCOMES IN PATIENTS WITH RA TREATED WITH ABATACEPT AND OTHER DMARDS: RESULTS FROM A 10-YEAR INTERNATIONAL POST-APPROVAL STUDY (2019) (1)
Solumatrix diclofenac safety in older patients with osteoarthritis pain (2015) (1)
Juvenile Dermatomyositis at Onset: Demographics, Clinical Characteristics, and Access to Care. ♦ 1844 (1997) (1)
Investigation of the genetic basis of rheumatic diseases (2008) (1)
FRI0229 Risk of Hospitalized Infections in Patients with Rheumatoid Arthritis Initiating Abatacept and Other Biologics: Analysis of A United States Claims Database (2016) (1)
Should There Be a Fracas Over FRAX and Other Fracture Prediction Tools (2016) (1)
276 RACIAL DIFFERENCES IN JOINT-SPECIFIC RADIOGRAPHIC HAND OSTEOARTHRITIS AND SELF-REPORTED HAND PAIN: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT (2007) (1)
Increases in Bone Mineral Density with Once-Monthly Ibandronate: A Post Hoc Responder Rate Analysis of the MOBILE Study (2006) (1)
Depression moderates analgesic effectiveness among individuals with radiographic knee osteoarthritis (2020) (1)
Osteoarthritis : New Insights Part 2 : Treatment Approaches Conference (2000) (1)
Habitual running does not increase risk for symptom or structure progression in those with pre-existing knee osteoarthritis: data from the osteoarthritis initiative (2015) (1)
349 DIFFERENCES IN VARUS AND VALGUS THRUST BETWEEN AFRICAN-AMERICANS AND CAUCASIANS: DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) (2008) (1)
THU0496 Combined Chondroitin Sulfate and Glucosamine is More Efficient than Celebrex in Reducing Serum Levels of COLL2-1, A Cartilage Degradation Biomarker, In Patients with Severe OA: Results from a Randomized, Double-Blind, Multicentric Clinical Trial (2015) (1)
Plane Dependent Subject-Specific Neuromuscular Training for Knee Rehabilitation (2020) (1)
Upper Gastrointestinal Tract Safety Profile of Alendronate (2017) (1)
Nutritional Associations With Glaucoma Among Older Black Women (2008) (1)
231 SYMMETRY OF RADIOGRAPHIC KNEE OSTEOARTHRITIS PROGRESSION IN SIBLING PAIRS WITH HAND OSTEOARTHRITIS (2007) (1)
FRI0151 Incidence Rates of Skin Cancers During Exposure to Intravenous and Subcutaneous Abatacept in Patients with Rheumatoid Arthritis: Results from Pooled Clinical Trial Data (2015) (1)
THU0128 GLUCOCORTICOID TAPERING IN MONTHLY 1-MG DECREMENTS DOES NOT RESULT IN CLINICALLY MANIFEST ADRENAL INSUFFICIENCY IN PATIENTS WITH RHEUMATOID ARTHRITIS: LEARNINGS FROM THE PHASE 3/4 SEMIRA STUDY (2019) (1)
319 DULOXETINE AS TREATMENT FOR KNEE PAIN IN PATIENTS WITH OSTEOARTHRITIS WHO REGULARLY USE NONSTEROIDAL ANTI-INFLAMMATORY DRUGS (NSAIDs): A POST HOC ANALYSIS OF TWO RANDOMIZED, PLACEBO-CONTROLLED TRIALS (2011) (1)
Racket or Bat Sports: No Association With Thumb-Base Osteoarthritis. (2022) (1)
A genetic analysis of osteoarthritis of the knee in north american caucasians: results from the osteoarthritis initiative and Johnston County osteoarthritis project (2012) (1)
FRI0534 Radiographic outcomes were associated with pain and function responses: post-hoc analysis from a phase 2 study of a wnt pathway inhibitor, sm04690, for knee osteoarthritis treatment (2018) (1)
American Academy of Family Physicians/American Academy of Orthopaedic Surgeons/American Association of Clinical Endocrinologists/American College of Rheumatology/The Endocrine Society/Physician Consortium for Performance Improvement® (2006) (1)
Bisphosphonates in the Treatment of Osteoporosis (1997) (1)
A Data Base Management System for Clinical and Epidemiologic Studies In Systemic Lupus Erythematosus: Design and Maintenance. (1984) (1)
Estimating the incidence and prevalence of rare rheumatologic diseases: a review of methodology and available data sources. (1990) (1)
SAT0131 Cumulative Disease Activity in Rheumatoid Arthritis and the Risk of Cardiovascular Events (2014) (1)
Non-conventional treatment of osteoarthritis by herbal medicine (2008) (1)
Enlarged acetabular labra in the Pima Indians. (1997) (1)
Traditional Chinese medicine in the management of osteoarthritis (2008) (1)
Comprar Hochberg. Rheumatology, 2-Volume Set, 5th Edition. EXPERT CONSULT - ENHANCED ONLINE FEATURES AND PRINT | Michael H. Weisman | 9780323065511 | Mosby (2010) (1)
FRI0095 Incidence of Malignancy in Adult Patients with Rheumatoid Arthritis: an Updated Analysis of the Literature (2014) (1)
An integrated safety analysis of lorecivivint, a novel, intra-articular CLK/DYRK1A inhibitor that modulates the WNT pathway, in subjects with knee osteoarthritis (2020) (1)
Overweight and Obese Have Similar Burden of Hip Fracture as Normal Weight Older Adults (2019) (1)
SAT0254 Patient characteristics and disease management of rheumatoid arthritis at baseline in the vigour (vioxx gi outcomes research) study: effects of disease duration (2001) (0)
352 THE ASSOCIATION OF GENES WITHIN THE VITAMIN D METABOLISM PATHWAY AND RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRHIS INITIATIVE GENOME-WIDE ASSOCIATION STUDY (2011) (0)
323 THE RELATIONSHIP BETWEEN KNEE-SPECIFIC AND PERSON-BASED WOMAC PHYSICAL FUNCTION SCORES: DATA FROM THE OSTEOARTHRITIS INITIATIVE (2008) (0)
THU0414 COMPARISON OF INTRA-ARTICULAR SHAM AND VEHICLE INJECTIONS FROM A PHASE 2B TRIAL OF SM04690, A SMALL-MOLECULE WNT PATHWAY INHIBITOR FOR KNEE OSTEOARTHRITIS (2019) (0)
Efficacy of NSAIDs in the Treatment of Rheumatic Diseases (2016) (0)
Proceedings of the Peking University 2011 Osteoarthritis International Forum (2011) (0)
SP0013 GROWTH FACTORS AND CARTILAGE: FROM MECHANISMS TO DMOADS (2019) (0)
arthritis events among patients with rheumatoid associated risk reduction of cardiovascular Tumour necrosis factor antagonist use and Setoguchi and (2011) (0)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2015): ESCEO Symposia Abstracts (2015) (0)
371 MRI-BASED CARTILAGE THICKNESS LOSS AND JOINT SPACE NARROWING IN AN OAI CORE PROGRESSION SAMPLE, AND THEIR RELATIONSHIP WITH AGE, SEX, AND BMI (2011) (0)
Renal Function and Bisphosphonate Safety (2007) (0)
OP0003 Association between disease severity and onset of depression in knee osteoarthritis (2018) (0)
Association between Obesity, Race and Knee Osteoarthritis: The Multicenter Osteoarthritis Study (2014) (0)
Osteoarthritis and Other Joint Involvement (2014) (0)
018 RELATIONSHIP OF WEIGHT CHANGE WITH CHANGE IN KNEE PAIN AND FUNCTION IN PERSONS WITH SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS: ONE-YEAR FOLLOW-UP DATA FROM THE OSTEOARTHRITIS INITIATIVE (2009) (0)
Letter to the editor (1994) (0)
Oral alendronate 10 mg daily does not cause serious sympotomatic gastroduodenal ulcers and complications (2000) (0)
A circulating anticoagulant to factor VIII in a patient with polymyositis: successful treatment with azathioprine. (1985) (0)
Bone structural changes and hip osteoarthritis: comment on the article by Javaid et al Reply (2010) (0)
Edinburgh Explorer Genome-wide meta-analysis of 158,000 individuals of European ancestry identifies three loci associated with chronic back pain (2018) (0)
OSTEOARTHRITIS OF THE KNEE. AUTHORS' REPLY (1997) (0)
307 THE RELATIONSHIP OF WEIGHT CHANGE WITH CHANGES IN KNEE PAIN AND FUNCTION IN PERSONS WITH SYMPTOMATIC RADIOGRAPHIC KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE (2008) (0)
Effect of multicomponent home-based training on gait and muscle strength in older adults after hip fracture surgery: a single site randomized trial. (2022) (0)
Reflections from the 2021 OARSI clinical trial symposium: Considerations for understanding biomarker assessments in osteoarthritis drug development - Should future studies focus on disease activity, rather than status? (2022) (0)
284 CROSS-SECTIONAL RELATIONSHIP OF KNEE INJURY/KNEE SURGERY TO TIBIO-FEMORAL OSTEOATHRITIS: BASELINE DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) (2007) (0)
Response to Boonen et al. ‘Assessing the relative efficacy of different osteoporosis agents based on the outcomes from meta‐analyses’ (2007) (0)
GARDENING/YARDWORK IS NOT ASSOCIATED WITH NEW KNEE PAIN OR DISEASE PROGRESSION OVER 48 MONTHS IN THOSE WITH KNEE OSTEOARTHRITIS: DATA FROM THE OSTEOARTHRITIS INITIATIVE (2022) (0)
Reply (2016) (0)
95 – Osteoarthritis and Other Musculoskeletal Diseases (2000) (0)
Association of Fruits and Vegetable Consumption and Glaucoma Among Older Women (2006) (0)
Comprar Rheumatoid Arthritis | Michael H. Weisman | 9780323054751 | Mosby (2008) (0)
Sports with a Bat or Racket are Not Associated with Thumb-base Osteoarthritis. (2021) (0)
Safety Research for Nuclear Reactors (NUSAFE): Transmutation – Liquid Metal Technology (2018) (0)
Baseline varus thrust and 3-year increase in denuded subchondral bone in persons with OR at higher risk for knee osteoarthritis (OA) (2013) (0)
Original article Mixed treatment comparison of efficacy and tolerability of biologic agents in patients with rheumatoid arthritis (2013) (0)
SAT0177 Safety events are similar with abatacept vs placebo treatment in ra: results from integrated data analysis from nine clinical trials (2017) (0)
Influencing mortality outcomes in RA. (1992) (0)
Factors associated with incident varus thrust in knee osteoarthritis: a prospective 2-year follow-up study (2013) (0)
ASSOCIATION OF PERSISTENT DEPRESSIVE SYMPTOMS WITH PHYSICAL ACTIVITY IN KNEE OSTEOARTHRITIS (2022) (0)
7 CHANGES IN PROXIMAL FEMORAL MINERAL GEOMETRY PRECEDE THE ONSET OF RADIOGRAPHIC HIP OSTEOARTHRITIS: THE STUDY OF OSTEOPOROTIC FRACTURES (2007) (0)
Predictors of mobility status one year post hip fracture among community-dwelling older adults prior to fracture: A prospective cohort study. (2023) (0)
Rheumatoid arthritis - treatment 180. Utility of Body Weight Classified Low-Dose Leflunomide in Japanese Rheumatoid Arthritis (2011) (0)
How to Interpret Surrogate Markers of Efficacy in Osteoporosis (2005) (0)
Sex Differences in Bone-Active Medication Utilization Before and During the Year After Hip Fracture (2020) (0)
530 THE EFFECT OF CHONDROITIN SULFATE ON STRUCTURE MODIFICATION IN PATIENTS WITH KNEE OSTEOARTHRITIS: A META-ANALYSIS OF 2-YEAR RANDOMIZED PLACEBO-CONTROLLED TRIALS (2008) (0)
Proceedings of the Second Update on Psoriatic Disease, University Federico II Congress Center, July 6–7, 2011, Naples, Italy. (2012) (0)
Menisci damage in knee osteoarthritis assessed by quantitative MRI testing is predictive of cartilage degradation progression (2003) (0)
A feasibility study of combined treatment using aerobic exercise and duloxetine in adults with symptomatic knee osteoarthritis and comorbid depression (2023) (0)
Association Between Cataracts and Incident Fractures Among Older Women From the Study of Osteoporotic Fractures (SOF) (2007) (0)
THU0200 Lower-Dose Solumatrix® Meloxicam: Efficacy and Safety in A Phase 3 Study in Adults with Osteoarthritis Pain (2014) (0)
Change in vertebral strength and bone mineral density in men and women over the year post-hip fracture: a subgroup analysis (2021) (0)
Corrigendum to “Prevalence of Fracture Risk Factors in Postmenopausal Women Enrolled in the POSSIBLE US Treatment Cohort” (2017) (0)
Tennis Is Not Associated With Symptomatic Radiographic Knee Osteoarthritis: Data From The Osteoarthritis Initiative (2023) (0)
Differing effects on hip and nonspine fracture risk reduction among N-containing bisphosphonates: Review and meta-analysis (2006) (0)
HEALTH ECONOMICS IN OSTEOARTHRITIS (2013) (0)
ALLELIC EXPRESSION ANALYSIS IN PATIENT TISSUES OF THE OSTEOARTHRITIS AND OF THE LUMBAR DISC HERNIATION SUSCEPTIBILITY LOCI (2012) (0)
EFFICACYAND SAFETYFROMAPHASE 2B TRIALOF SM04690, A NOVEL, INTRA-ARTICULARWNT PATHWAY INHIBITOR FOR THE TREATMENT OF OSTEOARTHRITIS OF THE KNEE (2021) (0)
SEX DIFFERENCES IN RECOVERY TRAJECTORIES AMONG HIP FRACTURE PATIENTS (2017) (0)
330 EFFECTS OF NAPROXCINOD AND NAPROXEN ON CHANGE IN JOINT SPACE WIDTH IN THE TIBIO-FEMORAL JOINT: RESULTS OF A 52-WEEK, RANDOMIZED CONTROLLED TRIAL (2010) (0)
AB0552 Relative efficacy and tolerability of intravenous and subcutaneous abatacept compared with tumor necrosis factor inhibitors in rheumatoid arthritis patients with an inadequate response to conventional disease-modifying antirheumatic drugs (2013) (0)
NSAID associated gastritis and Helicobacter pylori (I: Reply) (1990) (0)
SAT-382 Glucocorticoid Tapering in Monthly 1-mg Decrements Does Not Result in Clinically Manifest Adrenal Insufficiency in Patients with Rheumatoid Arthritis: Learnings from the Phase 3/4 SEMIRA Study (2019) (0)
Differences in geometric strength at the contralateral hip between men with hip fracture and non-fractured comparators. (2019) (0)
Silman Prognosis of osteoarthritis (0)
Title Bone mineral density and age-related maculopathy in older women Permalink (2017) (0)
THU0449 EFFECT MODERATION OF ANALGESIC TREATMENT OUTCOMES BY DEPRESSION IN PERSONS WITH OR AT-RISK FOR SYMPTOMATIC KNEE OSTEOARTHRITIS (2019) (0)
Estimating the impact of depressive symptoms on osteoarthritis pain using marginal structural models: Data from the Osteoarthritis Initiative (2016) (0)
World Congress on Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (WCO-IOF-ESCEO 2021): ESCEO Symposium Abstracts (2021) (0)
FRI0130 RELATIONSHIP BETWEEN DEPRESSION AND DISEASE ACTIVITY IN US VETERANS WITH EARLY RHEUMATOID ARTHRITIS RECEIVING METHOTREXATE (2019) (0)
Treatment of Rheumatoid Arthritis and Osteoarthritis Chronic Pain With Cox-2-Selective Inhibitors: A Managed Care Perspective (2002) (0)
9 Systemic lupus erythematosus (1991) (0)
Low-dose SoluMatrix meloxicam results in clinically meaningful improvements in pain in a phase 3 study of patients with osteoarthritis (2016) (0)
Addressing Concerns Regarding a Newly Proposed Knee Osteoarthritis Composite Symptom Score (2016) (0)
Osteoporosis: Treat current injury, retard future loss (1993) (0)
Chapter 24 – Osteoporosis (2010) (0)
Seminars in Arthritis and Rheumatism moves to online-only publication. (2022) (0)
15–year Decline in Visual Function in Older Women (2005) (0)
Introduction. New directions in anti-inflammatory therapy and pain management. (2002) (0)
Tibiofemoral knee osteoarthritis progresses symmetrically by knee compartment in the GOGO cohort (2022) (0)
Reliability of grading scales for individual radiographic features of knee osteoarthritis (1992) (0)
MANAGEMENT OF OSTEOARTHRITIS IN DIABETIC PATIENTS (2019) (0)
Case-control studies. (1983) (0)
Prediction models for incident slow gait speed over 10 years in persons at high risk for knee osteoarthritis (2019) (0)
OA for Beginners (2017) (0)
AB1359 Systematic literature review of publications on indirect comparisons for biologic agents in RA (2013) (0)
THU0372 Osteoporosis an Independent Predictor of Mortality in Hip Fracture Patients (2013) (0)
ThePrevalence andIncidence ofJuvenile Rheumatoid Arthritis Inan UrbanBlackPopulation (1983) (0)
Combined Chondroitin Sulfate and Glucosamine Is Comparable to Celecoxib for Painful Knee Osteoarthritis. Results from a Multicenter, Randomized, Double-Blind, PHASE IV NON-Inferiority TRIAL. (2014) (0)
Genetic Contributions to Early and Late Onset Ischemic Stroke (2021) (0)
Functional genetic polymorphism of IL-1rn encoding the IL-1 receptor antagonist predicts radiographic severity of symptomatic knee OA (2017) (0)
A 2-year evaluation of disease progression by quantitative magnetic resonance imaging in a large primary osteoarthritic patient population (2004) (0)
Year in review: clinical (2012) (0)
DETECTING COGNITIVE IMPAIRMENT AFTER HIP FRACTURE TO PREDICT DEMENTIA-RELATED CAUSE OF DEATH (2018) (0)
Osteoporosis Medication Use: A Comparison of Elderly Females Living in Long-term Care Facilities Versus Community Dwellers (2019) (0)
324 PHYSICAL INACTIVITY CHARACTERISTICS: DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) (2011) (0)
The Relationship Between Alcohol Consumption and Hip Fracture Recovery Among Older Adults (2020) (0)
Binocular visual field loss increases the risk of hip and non-spine, non-hip fractures (2004) (0)
Knee pain, strength and functional limitations in physically disabled older women (1997) (0)
Glaucoma and Sleep Problems Among Older Women: The Study of Osteoporotic Fractures (2009) (0)
SAT0428 Safety, Clinical and Imaging Outcomes of A Novel, Intra-Articular, Injectable, Wnt Inhibitor (SM04690) in The Treatment of Osteoarthritis of The Knee: Exploratory Analysis of Results from A 24 Week, Randomized, Double-Blind, Placebo-Controlled Phase 1 Study (2016) (0)
SAT0255 Regional variation in baseline patient characteristics and disease management of rheumatoid arthritis patients in the vigour (vioxx gi outcomes research) study (2001) (0)
Definition, classification and risk factors (2013) (0)
POS1138 PERSISTENCY OF DEPRESSIVE SYMPTOMS AND PHYSICAL PERFORMANCE IN KNEE OSTEOARTHRITIS (2022) (0)
Monthly ibandronate use is associated with a high percentage of BMD responders (2007) (0)
Performance of the OST risk tool for identifying men at risk of osteoporosis (2004) (0)
Significance of changing vs. stable pre-radiographic MRI lesions in persons at higher risk for knee osteoarthritis (2015) (0)
Osteoporosis an independent predictor of mortality in hip fracture patients (2013) (0)
Argon Gas Discharge Plasma for PWFA-Experiments at PITZ (2016) (0)
Two-year change in cartilage thickness on quantitative magnetic resonance imaging (qMRI) and joint space width (JSW) on X-ray demonstrate similar predictive performance for knee replacement in OA subjects eligible for clinical trials (2016) (0)
Sex Hormone Exposure and Age–Related Maculopathy in Elderly Women (2005) (0)
Prediction of incident radiographic disease and function outcome in a cohort of persons at higher risk for knee osteoarthritis (2016) (0)
Thomas Russell Hendrix, M.D. 1920-2013. (2015) (0)
Racial differences in pain reporting in subjects with OR at risk for symptomatic radiographic knee osteoarthritis: data from the osteoarthritis initiative (2012) (0)
310 PREDICTORS OF THE DEVELOPMENT OF SYMPTOMATIC KNEE OSTEOARTHRITIS IN THOSE WITH ASYMPTOMATIC RADIOGRAPHIC TIBIO-FEMORAL OSTEOARTHRITIS AT BASELINE: ONE-YEAR DATA FROM THE OSTEOARTHRITIS INITIATIVE (OAI) (2008) (0)
METABOLOMICS IN MEN WITH DISTINCT INFLAMMATION TRAJECTORIES FOLLOWING HIP FRACTURE REVEAL RESPONSE MECHANISMS (2019) (0)
Walking for exercise may be symptom and structure modifying for those with established osteoarthritis and with varus alignment - data from the osteoarthritis initiative (2020) (0)
A simple chart for evaluating risk of osteoporosis based on the Osteoporosis Self-Assessment Tool (OST) (2002) (0)
Pain reduction in either the knee or the hip with subcutaneous tanezumab: a pooled analysis in patients with moderate to severe osteoarthritis and a history of inadequate response to other analgesics (2021) (0)
Prevention of NSaiD-associated Gastric Ulcers: comparison of PN 400 (enteric-coated Naproxen with esomeprazole) Versus enteric-coated Naproxen alone (2011) (0)
Prescribed regimen is effective. Authors' reply (2010) (0)
Response to: ‘Concerns about report suggesting glucosamine and chondroitin protect against cartilage loss’ by Felson (2015) (0)
HOCHBERG : MORTALITY FROM SLE IN ENGLAND AND WALES (2005) (0)
Author ' s response to reviews Title : Low bone mineral density a significant risk factor for low-energy distal radius fractures in middle-aged and elderly men : A case-control study (2011) (0)
Association of Selenium Supplement Use and Intraocular Lens (IOL) Among Older Women (2007) (0)
Greater Gains in BMD with Once-weekly Alendronate Compared to Once-weekly Risedronate: 2-year Results from the FOSAMAX® ACTONEL® Comparison Trial (FACT) (2006) (0)
Evaluation of S201086/GLPG1972, an ADAMTS-5 inhibitor, for the treatment of knee osteoarthritis in ROCCELLA: a phase 2 randomized clinical trial. (2023) (0)
Osteoarthritis Research Society International (OARSI): Past, present and future (2021) (0)
The Omeract-Oarsi Core Set of Outcome Domains to Measure in Clinical Trials for People with Hip and/or Knee Osteoarthritis (2018) (0)
Response to: ‘Does MOVES move the needle?’ by Dr Meyer (2015) (0)
TWENTY-FOUR MONTHS OF OW ALENDRONATE 70 MG PRODUCES GREATER GAINS IN BMD AND GREATER REDUCTION IN MARKERS OF BONE TURNOVER THAN OW RISEDRONATE 35 MG WITH SIMILAR TOLERABILITY: 89 (2006) (0)
New Onset Juvenile Dermatomyositis (JDMS): Comparisons with a healthy cohort and children with juvenile rheumatoid arthritis. • 1845 (1997) (0)
Comprar Rheumatology e-dition Text with Continually Updated Online Reference, 2-Volume Set | Michael H. Weisman | 9780323044295 | Mosby (2007) (0)
Response letter to the Editor. (2021) (0)
Change in radiographic knee OA severity correlates better with change in composite pain and activity knee score compared with pain alone score (2018) (0)
Gout: prevention and management (1994) (0)
Elevated peripheral blood leukocyte inflammatory gene expression in radiographic progressors with symptomatic knee osteoarthritis: NYU and OAI cohorts (2015) (0)
Chapter 4 – Recommendations for Performing Bone Densitometry to Diagnose Osteoporosis and Identify Persons to Be Treated for Osteoporosis (2006) (0)
Prevention of osteoporosis. (1993) (0)
Effect of Multicomponent Home-Based Training on Gait and Muscle Strength Performance in Older Adults With Hip Fracture (2021) (0)
Weight loss is not associated with a reduction in the rate of decline in joint space width in subjects with symptomatic radiographic knee osteoarthritis: data from the osteoarthritis initiative (2012) (0)
275 RACIAL DIFFERENCES IN RADIOGRAPHIC OSTEOARTHRITIS OF THE LUMBOSACRAL SPINE AND LOW BACK PAIN: THE JOHNSTON COUNTY OSTEOARTHRITIS PROJECT (2007) (0)
Guidelines for the Management of Osteoarthritis of the Hip and Knee (1996) (0)
Efficacy of Tocilizumab Relative to Other Biologic Agents in Patients with Rheumatoid Arthritis and An Inadequate Response to Traditional Dmards: A Meta-Analysis with Mixed-Treatment Comparisons (2009) (0)
199 – Pathophysiology of osteoporosis (2015) (0)
Can we identify patients to be treated in osteoarthritis (2015) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Marc C. Hochberg?

Marc C. Hochberg is affiliated with the following schools:

University of Maryland, College Park

Marc C. Hochberg's Academic­Influence.com Rankings

Why Is Marc C. Hochberg Influential?

Marc C. Hochberg's Published Works

Published Works

What Schools Are Affiliated With Marc C. Hochberg?

Marc C. Hochberg's AcademicInfluence.com Rankings